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CHARACTERIZATION 0F PLASMACYTOID DENDRITIC CELLS
IN THE CD4C/HIV TRANSGENIC MOUSE MODEL
Plasmacytoid dendritic ceNs (pDCs), or interferon (IFN) producing ceils (IPCs), participate
in innate and adaptive immune responses against viral infections. Type I interferons exert
antiviral effects by direct inhibition of viral replication and stimulation of a variety
of immune ceil types. Murine pDCs are CD1 1 cb0B220+CD1 1 bGrl I0IL3RI0LY6Ch1 while
human pDCs are CD4+IL3RhiCD45RA+(B220)HLADR+. They are both identified as cells
that show plasmacytoid morphology, and reside in T cell zones of peripheral lymphoid
organs and in blood at a low frequency.
To study HIV-1-mediated pathogenesis, the CD4C/HlVmutG transgenic (Tg) mice have been
constructed in our Iaboratory. In this model, no viral infection and replication occurs but the
expression of HIV-1 nef gene in CD4T celis and in macrophages/DC lineages induces an
AIDS-like disease with several hallmarks of AIDS. These common features include CD4
down-regulation on T cells, depletion of of CD4 T cells, Iymphoid tissue atrophy and some
non-lymphoid organ pathologies. The immune system in this model is impaired in many
aspects and is under investigation. DCs other than pDCs display functional, maturational
and homing impairments in these Tg mice.
Here, we show that 25-40% ot pDCs express HIV-1 gene nef in Tg mice. Compared to
non-Tg, Tg-derived pDC show alterations in their frequency, maturation, localization and in
vitro response to stimulation. Also, based on preliminary results splenic pDCs from Tg
mice produce more IFN-a than their equivalents from nTg mice.
Considering the major immunoregulatory functions of pDCs, the observed changes in their
characteristics suggest their implication in the pathogenesis of the AIDS-like disease in
CD4C/HIV Tg mice.
Key words: AIDS, IFN-Œ, Antiviral immunity, Dendritic ceils, Nef, Lymphoid organs, CpG,
FLT3L.
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Caractérisation des cellules dendritiques plasmacytoides chez la souris
transgénique CD4C/HIV
Les cellules dendritiques plasmacytoides, aussi appelées cellules productrices
d’interferon, participent dans les réponses immunitaires innées et acquises contre les
infections virales. Les interferons de type I accomplissent des fonctions antivirales par
l’inhibition directe de la réplication virale et par la stimulation de plusieurs types de
populations cellulaires du system immunitaire. Le phénotype des cellules dendritiques
plasmacytoid chez la souris est CD1 1 cb0B220+CD1 1 bGrl IolL3RIoLy6ChI alors que chez
l’homme leur phénotype est CD4lL3RCD1 1cB22OHLA-DW. Les cellules dendritiques
plasmacytoid sont identifiées par leur morphologie similaire à celles des plasmocytes
autant chez la souris que chez l’homme. Elles représentent un faible pourcentage de la
population totale de cellules dendritiques et sont localisées dans les zones de cellules T
des organes lymphoïdes périphériques et dans le sang.
Afin d’étudier les mécanismes impliqués dans la pathogenèse du virus
d’immunodéficience humaine (VIH), la souris transgénique (Tg) CD4C,HlVmutG qui
exprime le gène nef du VIH, a été mise au point dans notre laboratoire. Dans ce modèle
murin, il n’y a ni l’infection ni la réplication virale, cependant une maladie ressemblante
au SIDA est induite par l’expression du gène nef du VIH-1 dans les cellules T CD4 et
les cellules des lignées macrophage/dendritique. Cette maladie et le syndrome
d’immunodéficience humaine ont plusieurs caractéristiques communes incluant la
régulation négative de l’expression de la molécule CD4 à la surface des cellules T, la
déplétion des cellules T CD4, l’atrophie des tissus lymphatiques ainsi que des maladies
des organes non-lymphoïdes. Dans ce modèle, le système immunitaire est défectueux à
plusieurs niveaux et ces altérations sont actuellement sous investigation. Une étude
récente a démontré que chez la souris Tg, les cellules dendritiques excluant les cellules
dendritiques plasmacytoides, ont des anomalies au niveau de leur fonction, état de
maturation et localisation.
La présente étude démontre que 25-40% des cellules dendritiques plasmacytoides chez
la souris Tg expriment Nef. Les cellules dendritiques plasmacytoides chez la souris Tg
présentent des altérations dans leur fréquence, maturation, localisation et leur réponse
in vitro aux stimulants. De plus, selon des résultats préliminaires, les cellules
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dendritiques plasmacytoides issues de la rate de la souris Tg produisent plus d’IFN-Œ
que leur équivalentes chez la souris non-Tg.
En considérant d’une part les multiples fonctions immuno-régulatrices que possèdent les
cellules dendritiques plasmacytoides et d’autre part les changements observés dans leur
caractéristiques principales chez la souris Tg, on peut suggérer que ces cellules sont
impliquées dans la pathogenèse de la maladie ressemblante au SIDA.
Mots clés: SIDA, L’immunité antivirale, Cellules dendritiques, Nef, Organes
lymphoïdes, CpG, FIt3L.
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CHAPTER 1: INTRODUCTION
7. INNATE AND ADAPTIVE IMMUNE RESPONSES
The immune system utilizes innate and adaptive responses in order to recognize and clear
pathogens from the host [1]. Innate immunity, which is antigen (Ag) non-specific, includes
natural barriers to pathogens such as skin and mucous membranes and specialized effector
celis such as phagocytes and natural killer (NK) celis [1]. Macrophages, neutrophils and
dendritic celis (DCs) at certain stage of their differentiation, show phagocytic functions. NK
celis are cytotoxic celis participating in innate immunity because of their ability to lyse virus
infected and tumor ceNs [1, 2, 3]. Phagocytes and cytotoxic NK celis, as the main players of
innate immunity, can discriminate between pathogens and self by utilizing signais upon
ligation of their ceN suriace pathogen recognition receptors (PRRs) [4, 5]. Innate immunity is
closely linked to and influences adaptive responses [6]. For example, proinfiammatory
cytokines produced by cells involved in innate immunity, enhance the Ag-presenting
capacity of DCs [6]. Adaptive immunity refers to Ag-specific responses including humoral
and cell-mediated defense mechanisms, which depend on B ceNs and T celis respectively
[1]. The acquired immune response has also a memory component that recognizes a
pathogen that has previously infected the host [1].
In adult, B and T ceNs develop from pluripotent stem cells in bone marrow (BM). Whiie B
ceils mature in BM, T ceNs complete their maturation in thymus where after undergoing a
selection process, only 5% of them survive and leave this organ. Negative selection induces
central tolerance through deletion of self-reactive T cells in order to avoid immune response
against self-tissues [1].
DCs process Ags and present them to T cells, in association with peptide-binding proteins
i.e. major histocompatibility molecule (MHC) for recognition by T cell receptors (TORs).
Intracellular Ags, processed into peptides in the cytosol of the antigen-presenting ceil
(APC), bind to MHC class I while extracellular Ags that have entered the endocytic pathway
of the APC associate with MHC class Il molecules [7]. CD4 T cells, also called helper T
cells, recognize Ag presented by MHC Class II and upon activation have profound immune
regulatory effects on processes such as antibody (Ab) responses, cytotoxic T lymphocytes
(CTL) responses and generation of memory cells. CD8 T ceNs are mainly CTLs that
recognize Ags presented by MHC class I. These cells participate in cell-mediated immune
defense [1, 8]. However, particular subsets of CD4 and CD8 T cells have also been
2attributed with major roles in inducing peripheral tolerance that together with central
tolerance taking place in thymus maintain the homeostasis of the organism [9, 10].
When CD4 T cells are primed upon Ag recognition, they become activated, expand and
release cytokines [1]. At this stage, helper T ceils are categorized based on the cytokine
profile they secrete [11]. CD4 T celis polarized as Thl produce interleukin IL-2 and IFN-y
stimulating ceil-mediated immune responses [1, 72]. Type 2 helper T cells (Th2) secrete
IL-4, IL-5, IL-6 and IL-10 and induce Ab secretion by B cells [11, 12]. Elaboration of each
class of cytokines, Thl or Th2, inhibits the production of the other class of cytokines [12].
Previously, it was believed that each DC subset was specialized for priming either Thl or
Th2 adaptive responses (DC1 for Thi inducers versus DC2 for Th2 inducers) [13].
However, ail DC subsets can initiate adaptive Th1-Th2 ceil responses and dictate the ciass
of T ceil immunity through the production of Th polarizing cytokines [11]. lndeed, the
cytokine microenvironment is central in T helper cell polarization toward Thl or Th2 celI
type during immune responses [14].
DCs can direct a Thi response, whenever the microbial stimuli that drive their maturation
elicit IL-12 production [11, 15J. IL-12 is a cytokine produced by mononuclear phagocytes,
DCs and activated NK celis inducing adaptive cell-mediated responses by promoting the
generation of Thl cells [1]. Also ail DCs can suppress Thi development and allow Th2
polarization upon exposure to IL-7 0 [1]. IL-70, produced by activated macrophages and Th2
polarized T cells down-regulates MHCII and costimulatory molecules on APCs [16]. It
conters tolerogenic properties to DCs and drives the generation of mouse CD4 Tr cells
[76]. IL-10 inhibits cell-mediated immunity favoring humoral responses [1]. Overall, a Thl or
Th2 response develops depending on antigen dose, the state of maturation of DCs together
with parameters such as kinetics 0f activation and the nature of the maturational stimulus of
DCs [11, 17,18].
2. CHARACTERIZATION 0F DCS AND THEIR ROLE IN THE IMMUNE SYTEM
DCs are a migratory group of BM-derived leukocytes with generally a short haif-Iife and a
fast turnover regenerating continuously f rom BM precursor cells through multiple
developmental stages. In BM, DC progenitors develop into immature precursors that
circulate in blood and home into various tissues throughout the organism. DCs represent a
network of APCs specialized in the capture, processing, transport and presentation of Ag to
T cells. They play a wide range of roles in initiation and regulation of immune responses
against pathogens and in homeostatic regulation. They are implicated in innate and adaptive
3immune responses and participate in the establishment of central and maintenance of
peripheral seif-tolerance [17, 19]. Central toierance is established by DCs presenting self
Ags to T ceNs that undergo the selection process in the thymus [9, 20]. Moreover, in the
absence of inflammation, DCs do not become fully activated and induce tolerance rather
than immunity [6, 9]. Indeed, contrary to activated DCs that produce immunity, immature or
quiescent DCs, i.e. mature DCs that are not fuily activated, induce peripheral tolerance
through multiple mechanisms. These inciude kiiling of T cells, paralyzing them (anergy)
or/and generating regulatory T celis [20, 21]. The tolerogenic potential of DCs correlates
with the absence of activation by proinflammatory signais [9, 21]. These signais are
responsible for the switch from a quiescent to an activated state in some DC lineages [20].
Proinflammatory signais reieased by infectious agents attract DCs to the site of
inflammation where they undergo a process caiied maturation that is required for their Ag
presenting function and for their migration into lymphoid organs. Once in lymphoid organs,
matured DCs induce T cell activation and initiate Ag-specific acquired immune responses.
Upregulation of ceii-surface MHC class Il and costimulatory moiecules i.e. CD8O, CD86 and
CD4O characterize DC maturation [21]. This process also causes the secretion of cytokines
and chemokines. MHC Il and costimulatory molecule expression on APCs provide the two
prerequisite signais to activate naïve T celis [1, 7]. Upon maturation, MHCII mainly residing
in intraceilular compartments, relocate from lysosomes to the celi surface [7]. Matured DCs
upregulate celi surface chemokine receptors (CCRs), which play a role in their migration to
T cell areas of iymphoid organs. Matured DCs also produce chemokines, which attract
various subsets of T ceils promoting DC-T celi interactions [18]. Thus, DC maturation is a
key control point in converting an antigen into an immunogen [21, 22]. This centrai role of
DC maturation in defense mechanisms is iiiustrated by the exampie 0f some tumor celis,
which secrete factors inhibiting DCs maturation in order to escape the immune responses
[6].
The interaction between NK celis and DCs may also be important in defense mechanisms.
DCs acquire the ability of regulating NK celis function early post-infection allowing the
production of cytotoxic and inflammatory responses that participates in the eradication of
the pathogen [3]. In fact, cytokines produced by different DC subsets enhance NK ceii
activation and cytotoxic function. These eftects are dependent on cytokines such as IFN-a
and IL-12 for NK ceil cytotoxicity and IFN-y secretion while tumor necrosis factor (TNF)-a s
required for CD69 expression. In addition, IL-2 activated NK cells interact with DCs and
induce their maturation [2, 3, 23].
43. DC CLASSIFICATION IN MICE AND HUMANS
DOs are a heterogeneous population of cells sharing major functional and phenotypic
features [17, 18]. Different DC subpopulations are distinguished based on ontogeny,
phenotype, function, localization and migrational characteristics and accomplish
complementary and overlapping functions in the immune system [18]. DCs can be obtained
in large number, both in vitro and in vivo, in the presence of Fms-like tyrosine kinase-3
ligand (FIt3L) that is a hematopoietic growth factor [24, 25]. This is because most DCs
develop from Flt3, hematopoietic progenitor cells in BM regardless ot their myeloid or
lymphoid origin [25, 26].
Mouse DCs are classitied into three subsets. The majority of mouse DCs are caIled myeloid
DCs (mDCs) because they originate from common myeloid precursors in BM. Lymphoid
DCs derive from common Iymphoid precursors, as do T cells. The myeloid DCs have a
characteristic celI surface phenotype, namely CD8aCD1 1 bCD1 1c, they are widely
distributed in Iymphoid and non-lymphoid tissues. Lymphoid DCs are CD8aCD1 1 bCD1 1 c
cells residing mostly in the thymus, but are also present in the periphery at a lower
frequencythan mDCs [15, 27].
More recently, plasmacytoid DCs (pDCs) with a particular morphology mimicking
immunnoglobulin (Ig)-secreting plasma ceNs have been characterized as a distinct DC
subset in mice and humans. Contrary to what was believed previously, mouse pDCs
develop efficiently f rom both Iymphoid and myeloid-committed progenitors in BM [9, 28].
PDCs are localized in peripheral and cord blood, in the thymus as well as in T celi areas
of secondary Iymphoid organs including peripheral iymph nodes (pLNs), spleen and
Peyer’s patches [11, 29]. They are identitied by their celi surface phenotype as
CD11cI0B22O+CD11bGr1I0IL3RI0LY6ChI. In contrast to other DCs that show a fast turnover,
pDCs in uninfected mice are Iong-lived and their frequency varies between different strains
and organs [30].
Human DCs are subdivided into two main groups including CD11c mDCs and CD11c
pDCs. Human pDCs phenotype is slightly different from mouse pDCs, since they are
CD4iL3RhCD45RA±(B220)HLADR+. In humans as in mice, mDCs constitute the
majoritary of DCs and include skin DCs called Langerhans cells (LC5) and interstitial DCs
(intDCs) residing in ail other tissues [31]. PDCs in human and mouse are equivalent in their
main function as they are both identified as the natural interferon-aipha (IFN-a) producing
ceNs (NIPCs) and they both can be mobilized by in vivo treatment with FIt3L [32].
54. CONVENTIONAL DENDRITIC CELL (CDC) FUNCTIONS
In this text the term cDC is used to designate ail mouse DCs including myeloid and
Iymphoid DCs, but excluding pDCs.
Various DC subsets difterentially control immune responses. There is a complementarity in
recognition as well as in effector functions among DC subpopulations [15]. CDCs Iink innate
and adaptive immune responses by activating both B ceils and NK cells [33]. Different
patterns of cytokine production by DC subsets may occur in response to particular
microbes. Also, different functions of Ag-presentation can be assigned to DC subsets
depending on the conditions cf stimulation [34]. Mouse Iymphoid DCs (CD8aCD11b),
produce IL-12 and prime naïve CD4 T lymphocytes to secrete Thi cytokines, whereas
mDCs (CD8c(CD11b) induce both Thi and Th2 cytokines following in vivo immunization
[15, 27]. However, only Iymphoid DCs possess the ability to cross-present Ag in association
with MHCI [34]. While mDC induce a strong allogeneic mixed-Iymphocyte reaction (MLR)
response, Iymphoid DCs induce a comparatively low MLR response and express Fas-Iigand
[35]. In fact, the limited CD4 T ceIl response induced by lymphoid DCs is associated with T
celI death that is caused by the interaction cf Fas on T cells and Fas-ligand on DCs.
Because of these characteristics, lymphoid DCs seem to play a regulatory function while
mDCs are stimulatory and induce a strong immune response [35, 36].
In humans, mature monocyte-derived DCs induce a Thi response causing the
differentiation cf naive CD8 T ceNs into cytotoxic T lymphocytes (CTL5) [10, 36]. Apart f rom
their role in T cell priming, cDCs activate NK cells and control B celI growth and
differentiation [30, 37]. They also participate in innate responses through functions such as
pathogen recognition and phagocytosis [2, 3, 4]. In addition, follicular DCs (FDC5) reside in
follicles cf lymphoid organs and retain Ag in a native state for presentation to germinal
center (GC) B cells [1]. FDCs are responsible for B celI activation and selection through the
process of affinity maturation [1]. On the other hand, thymic DCs derive from an intrathymic
precursor, develop and die within the organ. They show a non-migratory behavior and
participate in the induction cf central tolerance [20].
5. PLASMACYTOID DC f PDC) FUNCTIONS
Previously, pDCs were called plasmacytoid T cells or monocytes based on their tissue
localization in T celI rich area of lymphoid organs, their round morphology with a smooth
plasma membrane and an eccentric nucleus resembling plasma cells [38]. Studies showed
6that non-monocytes, non-T and non-B plasmacytoid lymphocytes can activate NK cells, in
vitro [39]. Later, pDCs were classified as a distinct subset of DCs because of their lack of
lineage markers, the expression of MHCII and the capacity to stimulate naive T ceNs [40,
41]. lndeed pDCs do not express typical ceIl surface markers of T celis, such as CD3, B
cells, such as CD19, monocytes, such as CD14 or NK ceils, such as CD16 and CD56 [42].
Currently, they are recognized as IPCs, which upon microbial and especially viral infection
are able to activate NK ceils as weIl as regulate the immune responses. It is now known that
IPCs are necessary for NK celi activation partly because IFN-u enhances NK celi
cytotoxicity [2, 43].
PDCs are implicated in innate and adaptive immune responses to viruses [11, 31]. Upon
microbial infection, pDCs accomplish their functions partly through the secretion of IFNa.
PDCs produce up to 1000 times more IFN-a in response to viral stimulation than any other
peripheral blood mononuclear celis (PBMCs) [32]. Apart from NK cell activation that was
originally attributed to pDCs, IFN-a plays multiple immunoregulatory functions including
differentiation of monocytes into dendritic-like celis, maturation of mDCs and pDCs, Thi
polarization of unpolarized Ag-experienced CD4 T cells and the differentiation of B cells into
plasma cells [44, 45, 46]. Since DCs are the most potent APCs but are at 10w frequency in
the organism, the ability of pDCs to promote monocyte-derived DCs amplifies total Ag
presenting function [7, 47]. This IFN-a-mediated effect of pDCs on monocytes and mDCs
indirectly regulates T celI responses [47]. Type I IFNs are also important for pDC maturation
since their maturation is drastically impaired in IFNo—receptor (IFNAR)-deficient mice [39].
In the context of viral infection, pDCs sense the presence of the virus through TLR7 and
TLR-9 expressed in their endosomal compartment [48]. Upon viral recognition, pDCs control
innate immune celI functions as they activate macrophages and NK cells through release of
cytokines. In fact, pDCs responses to viruses include the production of IFN-a, IL12,
chemokines f CC5) such as CXCL9 and CXCL1 O and chemokine receptors (CCR5) such as
CCR3, CCR4 and CCR5 [44]. AIl these factors affract and activate NK ceils and T cells and
modulate the function of mDCs by inducing their maturation [45, 46, 49].
The production of type I IFNs is exclusively reserved to immature pDCs. In fact, as pDCs
mature, they ose the ability to produce IFN-a and acquire the ability to present Ag to T cells
[42]. Thus, pDCs show a dual Ag-presenting and IFN-producing function that links innate
and adaptive immunity [50]. However, pDCs possess a weaker ability to stimulate naive
CD4 T cells than mDCs. PDCs are less potent APCs than mDCs because they express
Iower celI surface MHCII and costimulatory molecules, do not endocytose Ag as efficiently
7as mDCs and Iack the expression of lysosomal proteases involved in Ag processing [42,
44]. PDC and mDC differ also based on various sets cf PARs that they express (see
section on TLRs). Moreover, while immature as weIl as mature mDCs morphology includes
cellular protrusions called dendrites, immature pDCs are round and Iack dendrites. PDCs
can deveiop dendritic protrusions only upon maturation and transformation into APCs [27,
35]. It is possible that pDCs induce the differentiation cf unpoiarized Ag-experienced T celis
that have previously been expanded by mDCs [44].
Despite the difficulty to study pDCs because cf their low frequency in blood and secondary
lymphoid organs cf both human and mouse, different research groups have investigated the
APC function cf pDCs [51]. These experiments include in vivo and in vitro assays using
different stimulants such as CD4O ligand (CD4OL), IL-3 or viruses. CD4OL is a weIl-known
DC activator expressed on many ceIl types including helper T cells and seems to amplify
activation of DC previously stimuiated by infectious agents [52]. IL-3 s a potent maturation
and survival factor for human pDCs [53]. However, it shouid be noted that IL-3 and CD4OL
are factors produced by T celis atter their activation and in early responses te viruses, these
signais cannot dictate DC differentiation [54].
In mouse, upon microbiai, IL-3 or CD40L stimulation, pDCs differentiate into CD8DEC205
DCs distinct from Iymphoid CD8DEC205 DCs [50]. Microbial infection can thus induce the
generation cf a new DC subtype flot present in uninfected organism. Although the complete
functional implication cf this shift in the DC network remains te be determined, it is known
that mature CD8DEC205 pDCs can efficiently present Ags to T celis and to a lesser extent
than mDCs induce Ag-specific adaptive responses [50]. Mutine pDCs generally promote
Thi responses at high and Th2 responses at low antigen dose. It has been shown that viral
stimulation cf pDCs induces IFN-a production and their differentiation into Th1 polarizing
DCs [12, 55, 56]. Other experiments in mouse show that influenza virus stimulation cf pDCs
in vivo results in their differentiation into APCs. These matured pDCs induce
effector/memory CD8 T celI responses that could be recalled 4 weeks later [43].
In human, pDCs difterentiate into CD11c mature DCs when cultured with IL-3 and CD4OL.
These CD4OL and IL-3-treated pDCs have been shown to stimulate CD4 helper T cells,
which become Thl-polarized in vitro due te the synergistic effect cf IL-12 and IFN-a [56].
However, prier te these findings, human pDCs were called precursors cf DC2 because upon
stimulation with CD4OL or viruses in vitro, they induced an IL-4-independent Th2
polarization cf naive T cells [57]. In contrast to DC2s, monocyte-derived DCs were termed
DC1s because they induce Th polarization and pro-inflammatory responses [57]. However,
8since type I IFNs promote a Thi response in humans, this view of pDCs as precursors of
DC2s does not correlate with their ability to produce type I IFNs [42, 57]. The discrepancy
between these resuits could reflect various conditions of in vitro pDCs exposure to CD4OL
and methods used to culture them [45, 57]. In vivo, DCs shouid receïve signais with a
different strength in a sequentiai fashion, preserving the plasticity of the DC’s Th polarization
function until the final stages of their maturation in the iymph node [57]. Accordingly, in order
to accomplish aN these diverse functions, pDCs must migrate from biood into inflamed LNs
[49].
Other in Wtro studies on human pDCs show that they influence the humoral immune
responses. When activated T ceNs secrete IL-2 and express CD4OL, these factors signai
pDCs to secrete IL-6. PDC-derived IFN-a/r3 induces B ceils ta differentiate into plasma
biasts whiie pDC-derived IL-6 is responsible for inducing their Ab secretion [58]. Thus, in
vitro, virus-activated pDCs induce the differentiation of CD4O-activated B celis into plasma
cells producing virus specific Abs [43, 58].
On the other hand, a role for the induction of tolerance was attributed to pDCs. In vitro
studies show that immature human pDCs can differentiate CD8 Tr ceNs that suppress Ag
specific T celi proliferation [31, 58]. These Tr cells produce IL-10, which is implicated in
immuno-suppression [10, 43, 59]. IL-10 producing CD8 Tr cells inhibit Ag-specific
proliferation of naive CD8 T ceNs in a primary MLR [59]. Another study reported, that
CD40L-activated pDCs similar to immature mDCs have the ability to induce primary Tr-cell
differentiation permitting peripheral toierance [59]. One study on human pDCs demonstrates
that TLR-9 stimulation of pDCs promotes the generation of CD4CD25 Tr celis in vitro [60].
Studies in mice also support that pDCs play a raie in the generation of CD4 Tr cells [60].
Overall, the production of IFN-a by pDC initiates innate immune responses Iimiting the
spread of pathogens and promotes adaptive immune responses by enhancing the function
and maturation of APCs including monocytes and mDCs [47]. Also, when matured, pDCs
participate directly as APCs in adaptive responses. Thus, pDCs initiate an immune
response through the secretion of cytokines and link innate and adaptive immunity upon
activation [42]. PDCs show great flexibiiity in their functions and depending on the stimuli
they receive, they can induce Thi, Th2 or regulatory (Tr) responses [31, 50, 55].
Several studies have shown heterogeneity in pDC population [50, 51]. PDCs phenotype can
be used ta identify their subtypes since pDCs have been ciassified on the basis of celi
sur[ace CD4 expression. CD4 pDCs have been shown ta be functionaily distinct from CD4
9pDCs. CD4 pDCs do flot produce IFN-Œ although they show similar MHCI1 expression to
CD4 cells [50]. Kinetic studies have shown that CD4 pDCs are precursors of CD4 pDCs.
Moreover, blood CD4 pDCs are the precursors of spienic CD4 pDCs, which are the
precursors of splenic CD4 pDCs [50].
In addition, BM pDCs f rom mouse could be classified based on the expression of Ly49Q
[51]. Ly49Q, a type II C-lectin membrane-associated polypeptide, is a member of Ly49 NK
receptor subfamily that binds to MHCI and regulates NK ceil activation. However, Ly49Q is
expressed on ail peripheral pDCs but flot on NK or NKT cells [51]. Ly49Q is flot exclusively
expressed by pDCs since Gr1 myeloid Iineage celis and activated macrophages have been
reported to express this celI surface molecule [61]. In BM, the expression of Ly49Q defines
two subsets of pDC [51]. Different expression level of Ly49Q defines sequential
deveiopmental stages of pDCs derived from BM by using cytokines such as FIt3L [62]. One
study showed that Ly49Q pDCs respond less to infectious agents than Ly49Q pDCs
possibly because they have flot yet acquired the full sets ot ceil surface and/or signaling
molecules necessary for their functions against microbes [51]. Accordingly, a correlation was
found between Ly49Q expression on pDCs and their maturational state [61]. In fact, Ly49Q
pDCs are mostly CD4 and upon activation they become Ly49Q and concomitantly
upregulate celi surface expression of CD4 and MHCII [61, 62].
6. PDCS AND MYELOID DCS (MDCS) MIGRATIONAL PROFILES
DC development includes distinct stages. In BM, first DC progenitors proliferate and give
tise to DC precursors, which circulate in blood. Blood DCs migrate to sites of inflammation
in response to chemotactic stimuli and from there they are recruited into secondary
lymphoid organs to prime T cells. Thus, DCs migration is critical for optimal immune
responses [56]. Migration of leukocytes is a complex process to which CCs contribute [44,
63]. Pathogens induce local production of TNF-a, which once in circulation promotes
systemic inflammation and up-regulates CCL3 causing mobilization of DC precursors into
the blood [64, 65]. These precursor ceils develop into immature DCs that localize in various
non-lymphoid tissues in order to capture Ags upon invasion of the host by foreign agents. In
general, immature DCs express receptors for inflammatory CCs, which facilitate their
migration to sites of inflammation [11, 15]. Local TNF-a accelerates influx of mDC
precursors to sites of inflammation via CCL3 and their efflux via CCL21 [64]. Once there,
they respond to inflammatory cytokines secreted by innate immune celis that promote their
maturation after capturing Ags [11, 15]. Upon maturation, DCs show a CCR switch, down
regulating inflammatory CCRs (CCR5, CCR2 and CCR1) and up-regulating CCR7 [16]. The
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interaction of pathogens with innate immune celis aiso induces the release of
proinflammatory signais that cause DC migration to T ceil rich zones of Iymphoid organs
(spleen and LNs) for Ag presentation and T ceil priming [11, 63, 66]. in fact, upon
maturation DCs up-regulate cell surface CCR7, a receptor for SLC/CCL21 and ELC/CCL1 9,
which are constitutively produced in T ceH areas of secondary lymphoid organs and drives
DC migration to these sites [11, 15].
Serum TNF-a also up-regulates CXCL9 and E-selectin on LN high endothelial venules
(HEVs), which attracts pDCs to cluster around HEVs. HEVs are speciaiized post-capillary
blood vessels with a cuboidal endothelium, which constitute one of the entry routes to T cell
zone of LNs for biood lymphocytes [1, 67]. It is now known that it is around HEV5 where
pDCs produce large amounts of type I IFN [56, 64, 65]. CXCR3 is required for this
migration, because in CXCR3-deficient mice, trans-HEV migration of pDCs into LNs from
biood is impaired, [56, 64]. In contrast to pDCs, mDC precursors as well as monocyte
derived DCs that have captured Ags migrate into the draining LNs through afferent
iymphatics [11, 64, 65].
in human blood, pDC and mDC express similar sets of CCRs with the exception of CCR7
and CXCR3. Expression of CXCR3 and CCR7 is low on mDCs and high on pDCs [13].
Following maturation, both pDCs and mDCs downregulate CCR1, CCR2, CCR5, CCR6 and
CXCR1 and strongly upregulate CCR7. However, in contrast to mDCs, most CCRs
expressed on pDCs are flot functional on circulating cells [13, 66]. in fact, only after
maturation induced by stimulants, such as CD4OL, are the receptors for inflammatory
chemokines downregulated, and CCR7 on pDCs becomes functional and induces migration
[13]. The differences between mDC and pDC migration include the expression of CCRs
such as CCR7 and CXCR3, direct entry of pDCs to LNs from blood while mDCs enter LNs
through afferent lymphatics and the fact that on some pDC, CCRs are flot functional when
they circulate in blood [13]. These differences in migration between pDCs and mDCs,
suggests a distinct role for each subset in the induction and regulation of the immune
responses [13]. Accordingly, PDCs could be more involved in homeostatic control of
immune responses since they can induce Thi, Th2 and possibly Tr cells depending on the
conditions [13]. In addition, virally stimulated pDCs have been shown to produce CCs such
as CCL4 and CXCL1 O that attract NK and activated T cells to pDCs [65].
11
7. TLR DEFINITION AND ROLES IN THE IMMUNE SYSTEM
The innate immune system is the first une of defense against pathogens and allows the
initiation and regulation of adaptive immune responses for effective clearance cf infectious
agents [54]. To detect the presence of infection, the innate immune system first recognizes
conserved molecular structures that are predominantiy found in microorganisms but not in
vertebrates [5, 68, 69]. Pathogen associated molecular patterns fPAMP5) are recognized by
various types of PARs expressed on innate immune ceils including monocytes,
macrophages, DCs, B celis and NK cells [5]. Among these cells, effector ceils, such as
neutrophils and macrophages, exert phagocytic and/or cytotoxic functions upon binding cf
PAMP5 te PRRs [5, 68]. A major part of PRRs is represented by Toli-Like receptors (TLR5),
which constitute a group of transmembrane signaling receptors [70]. Ten different TLRs in
human and twelve in mice have been described [70]. They belong to phylogeneticaily
conserved factors that generate selective immune responses upon ligation by various
PAMPS [70, 71]. TLRs ligation activates NFKB transcriptional factor and induces the
expression of many genes involved in immune responses [5, 72]. The responsiveness to a
given PAMP depends on the set of TLR expressed by the ceil. Ail TLRs permit to mount a
f irst set of stereotyped responses such as inflammation. Individual TLRs induce distinct set
of immune responses necessary for host defense. For example, intracellular pathogens
require Thi polarization of CD4 T cells [5, 15, 73].
It is known that TLR1 is required for the response to imiquimod, TLR2 to peptidoglycan
(PG) and mycobacteria, TLR3 to double stranded fds)-RNA (viruses), TLR4 to LPS, TLR5
to flagellin, TLR7 and TLR8 to G/U rich single-stranded (ss) RNA or imidazoquinoline, TLR9
to intracellular bacterial and virai DNA or CpG ODN [3, 68]. In humans TLR7 and TLR 9 are
expressed by B ceNs and pDCs, while TLR2, TLR3, TLR4 and TLR8 are expressed by
mDCs and monocytes [3, 68]. In the mouse, expression of TLR9 is not exclusive to pDCs
and B cells and other DCs as well as macrophages express TLR9 [68].
MDC and pDC express complementary sets of TLR, providing them the capacity to respond
to different PAMPs [11]. While TLR4 and TLR3-mediated mDCs activation by LPS and
Poly(I:C) respectively, causes their IL-12 production, TLR9 ligation to CpG induces IFN-a
production by pDCs [50, 74]. LPS is a major component of the ceil wall cf Gram-negative
bacteria and PoIy(l:C) mimics viral dsRNA that is released after virally infected ceil lysis [75,
76]. The differential expression of TLRs by human DC subsets could explain selective
immune responses to various pathogens. TLR9 signaling induces the maturation of pDCs
among human DCs and of pDC and mDC among mouse DOs. ut aIse activates matured
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DCs to produce cytokines. Thus, TLR-signaling pathways iink innate and adaptive immunity
by promoting Ag-presenting function of DCs that allows in turn the generation of adaptive T
ceil responses [35].
In order to induce an efficient adaptive immune response, TLR signaling must also block the
suppressive eftect of Tr cells on T celis. Indeed, as mentioned earlier, Tr ceNs prevent the
activation of peripheral auto-reactive T ceils. It has been postuiated that TLR signaling
induces the concomitant secretion of IL-6 by DCs. Since IL-6 renders pathogen-specific T
ceils refractory to the suppressive effect of CD4CD25 Tr celis, TLR-signaling can
overcome peripheral toierance and induce an immune response [77].
Pathogen-derived DNA recognition as non-self by mammalian immune ceNs through TLR9
signaling pathway is due to its high frequency of unmethylated CpG dinucleotides. In fact,
mammalian-derived DNA has much lower frequency of these dinucleotides and they are
mostly methyiated [63, 71, 78]. CpG ODNs are synthetic compounds that mimic microbial
DNA and interact with TLR9 specifically, as shown by the absence of CpG effects in TLR9-
deficient mice [71]. CpG effects include proliferation of spienocytes, inflammatory cytokine
production and maturation of DCs [71]. In addition, TLR9-engaged pDC activate NK celis as
indicated by CD69 upregulation and enhanced cytotoxicity. One study showed that IL-2
produced by CD4 heiper T cells enhances NK cells activation, while Tr ceils cancel this
additive action by blocking CD4 T ceIi-mediated enhancement of NK ceil activation [79].
In mice, CpG ODNs promotes MHCI presentation of soluble Ags to CD8 T celis inducing
Thi-type ceIl-mediated responses independently of CD4 T celi help. This characteristic of
CpG could potentially be useful in the treatment of chronic viral infections such as HIV,
where there is progressive Ioss of Thi immune responses along with depletion of CD4
helper T cells [47].
8. INTERFERON (IFN)-ALPHA DESCRIPTION AND FUNCTIONS
IFN-o and IFN-13, are classified as type I IFN5 whiie IFNy corresponds to type II [69]. IFN-y
is an antiviral agent as weIl as an activator of CTLs and is one of the main cytokines
produced by Thl-polarized CD4 heiper T ceils, CTL type I and NK cells [53, 58]. Type I
and II IFN5 have non-redundant and complementary functions in the host response to viral
infection [80]. Type I IFNs are inducible cytokines produced by different celi types in
response to viral infection and exert an antiviral activity at ail stages of virus life cycle [80,
81, 82]. In the mouse, 1 IFN-3 and 13 IFN-a have been identified and are encoded by an
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intronless multigene family [81]. Fibroblasts, T ceNs, macrophages, monocytes, DCs and
NK cells secrete IFN-a [80]. However, pDCs identified as NIPCs produce up to 1000 times
more of this cytokine than any other ceIl type [80]. Type I IFNs bind to a common receptor
IFNAR that is expressed on a large variety of ceIl types [70].
Stimuli, such as viral components, endotoxin treatment of cells, UsRNA, poly (I: C) or CpG
ODNs can induce IFNa production [80, 83]. IFNa/j3 acts directly on most ceIl types and
turns on biochemical pathways, which induce an antiviral state. IFNaI3 antiviral effects
include the restriction of viral replication and confer cellular resistance to further viral
infection [58]. Various proteins are involved in IFNa/r3 induced antiviral state including PKR,
ADAR (adenosine deaminase acting on RNA), CAS (2’,5’-oligoadenylate synthetase),
RNase L and MX proteins [80, 84].
Protein kinase receptor (PKR) is a cytoplasmic serine-threonine kinase containing two
conserved d5RNA-binding domains in its N-terminal region. PKR belongs to a class of more
than 20 dsRNA-binding proteins, which recognize non-specifically dsRNA. Once activated,
PKR phosphorylates the protein synthesis factor eIF-2a, which inhibits initiation of viral
translation and consequently interteres with viral replication. Numerous viruses encode
genes responsible for inhibiting PKR activity. ADAR inhibits ANA editing; CAS activates the
endoribonuclease RNase-L to degrade s5RNA [80, 84] Human MxA protein and mouse Mxl
are IFN-induced GTPases that inhibit replication of certain viruses by binding target viral
proteins [74]. Many viruses have developed mechanisms to escape the inter[eron system
by inhibiting its synthesis or blocking its action as for example through suppression of PKR
activation [4, 74].
Moreover, lFNaIr3 regulates functions of immune cells, enhancing humoral and cellular
antiviral responses in vivo [32, 82]. These regulatory functions on immune cells include the
activation of NK ceNs by promoting their survival and proliferation through IL-15 production.
IFNa/j3 activates CD8 and CD4 T cells and has an effect on proliferation of B celis. Type I
IFN5 drive monocyte differentiation into DC-Iike ceNs, maturation of DCs as well as
differentiation of pDCs into efficient APCs. IFN-a mediates its immunoregulatory functions in
part through the modulation of the activity of other cytokines and CCs such as IFNy, IL-1,
1L2, IL-3, IL-8, IL-12, IL-13, IL-15, TNF-a, IP-l0, etc [68, 80]. IFNa/F3 also affects expression
of ceIl surface cytokine and CC receptors. For example, it causes IL-12R up-regulation on
CD4 T cells promoting Th-1 polarization of helper T cells [80]. Moreover, IFN-a as weII as
IFN-y enhances immunoglobulin G (lgG) production and downregulation of IgE secretion by
B cells, promoting humoral immunity [80]. IFNa43 is an important cytokine in innate immune
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responses since it activates innate immune celis such as NK ceNs to kiil virally infected
ceNs. This cytokine also causes up-regulation of MHCI and MHCII on APCs and promotes
adaptive immune responses by CD8 and CD4 T celis respectively [85] Thus IFN-a bridges
the innate to adaptive immune responses through the increase of total APC function [80]
(See supplementary figure 11).
Studies investigating IFN-u production in response to pathogens show that this cytokine has
very rapid kinetics and disappears after about 24 hours. This suggests that pDCs initiate an
antiviral innate immunity early during viral infection. The capacity of pDCs to produce great
amounts of IFN-a rapidly and effectively in response to viral pathogens is due at least in
part to a specific genetic program [86]. IFN-a acts through multiple signaling pathways
involving JAK kinases, STAT transcription regulators and IRF transcription factors [80, 84].
The induction of IFN-a secretion requires a positive feedback-loop as shown by
IFNAR-deficient celis, which are inhibited in their production of IFN-a [83]. However, mouse
and human pDCs rather than other ceil types can bypass the positive feedback loop that is
essential in the production of IFN-a. It has been reported that IRF7, which interacts with the
adaptor protein MyD88 is required for type I IFN production in response to TLR7 and TLR9
through the signaling pathway involved in the positive feedback Ioop [39, 86]. Both human
and mouse pDCs constitutively express higher levels of IRE-7 than other celI types allowing
them to bypass the positive feedback in IFNaI3 signaling that requires de novo IRE-7
synthesis [39, 86]. Moreover, the production of high-Ievel type I IFNs in response to TLR9
necessitates the retention of MyD88-IRF-7 complex in the endosomal compartment for an
adequate lapse cf time and this spatiotemporal regulation is observed only in pDCs [39, 87].
9. HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION
9.1. HIV DESCRIPTION
Human immunodeficiency virus fHIV) is a retrovirus, a family member of lentiviruses that
causes an infection cf the immune system leading to the acquired immunodeficiency
syndrome (AIDS) [67, 88]. The HIV genome contains two ssRNA molecules, each 9.2 Kb
long, bound to a molecule of reverse transcriptase. Following entry into host cells, the viral
reverse transcriptase copies the RNA into d5DNA. This viral DNA integrates into the host
cell DNA and becomes a provirus. HIV genome is composed cf nine genes flanked by non
coding long terminal repeats (LTR5) that are necessary for the integration of the provirus
into the host ceil genome. LTR5 also contain binding sites for gene regulatory proteins that
control the expression cf the viral genes and are required for viral replication. HIV RNA is
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within a core of viral proteins and surrounded by a nucleocapsid. The outer portion of the
nucleocapsid consists of a phospholipid bilayer envelop derived from host celI containing
virally encoded envelop glycoproteins, gpl2O and gp4l which are required for the infection
of cells [67, 88, 89].
HIV-1 possesses three typical retroviral genes: the gag gene encodes core structural
proteins, the env sequences encode gpl2O and gp4l of the viral envelop, mediating the
membrane fusion required for the entry of the virus into host ceils and the p0! sequences
encode reverse transcriptase, integrase, and viral protease enzymes necessary for viral
replication. In addition, H IV-1 genome also includes six other regulatory genes, the tat, rev,
vif, nef vpr, and vpu genes [1]. Vif enhances infectivity, Vpr promotes nuclear import of viral
DNA and arrest ceIl cycle at G2 phase, Tat is necessary for elongation of viral transcripts
and markedly augments viral transcription independently of the integration site, Vpu
downregulates CD4 expression and augments viral release f rom ceNs. HIV-1 -protein Nef,
also down-regulates MHCI. Tat and Rev are necessary for HIV replication. The Tat protein
functions as a transactivator of the HIV promoter and Rev facilitates the cytoplasmic export
of incompletely spliced transcripts. Vif, Vpr, Vpu and Nef are termed accessory because
their inactivation does not totally block HIV replication in vitro. However, these genes are
important virulence factors [89, 90].
Since the CD4 molecule functions as a receptor for the virus, HIV infects CD4 cells
including CD4 T cells, monocytes and DCs [67, 88, 91]. Membrane fusion between the Iipid
bilayers of the viral envelope and the host ceil membrane is required for viral entry to the
cell. The gpl2O/gp4l -Env complex catalyses the membrane fusion by interacting with host
cell CD4 molecule and coreceptors. [89]. Host celI coreceptors for viral membrane
glycoproteins are CXCR4, expressed on macrophages, and CCR5 by T ceils. Certain HIV
isolates, replicate efficiently in primary macrophage culture and are termed ‘TM”—tropic or X4
for CXCR4. Other isolates replicate in T cells but not in macrophages and are called “T”
tropic or R5 for CCR5 [89].
9.2. THE CLINICAL COURSE AND IMMUNOPATHOGENESIS 0F HIV INFECTION
There are two strains of HIV, called HIV-1 and HIV-2. HIV-1 is the most common cause of
AIDS. However, HIV-2, which differs in genomic structure and antigenicity, induces a similar
clinical syndrome [92]. The clinical course of HIV infection includes an acute infection with
high level of viremia, followed by a latent stage, where the immune response controls
infection but the virus persists as a provirus in infected cells [92]. Initially, HIV infection
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induces specific humoral and celI-mediated anti-HIV immune responses [91]. During the
latent phase, LNs and spleen are sites of ongoing HIV replication and tissue destruction.
HIV infection progresses to AIDS when destruction of lymphoid tissue is complete and
blood CD4 T cells drops below 200 cells / mm3 [1]. AIDS includes various signs and
symptoms such as weight Ioss, night sweats, fever and diarrhea. AIDS is a state of
suppressed immunity mainly because of the loss of CD4 helper T cells and impairment of
adaptive immune responses [93]. AIDS immunosupression underlies the development of
opportunistic infections (Cl) and neoplasia [93].
The latent stage can vary f rom less than 1 year to 15 years. The outcome of HIV-1 infection
depends on the host anti-viral immune response. Long-term non-progression (LTNP) status,
defined by at least 10 years of HIV infection without the development of AIDS, is associated
with the development ot effective and persistent T ceIl responses against HIV [24]. The
clinical stages of HIV disease correlate with a progressive spread of HIV from the initial site
of infection (i.e. blood or mucosa) to lymphoid organs. In early HIV-1 infection, gut
associated lymphatic tissue (GALT) is a principal site of virus replication and depletion of
primarily lumina propria memory CD4 T cells. The immune response controls temporarily
the acute infection but a chronic infection is established when virus trapped in lymphoid
tissues by FDCs persists [1].
The major hallmark of the suppression of immune responses in HIV-1 infected patients is
the progressive decline in the number of CD4 T cells. In fact, the consequences of HIV
infection of T cells are devastating because the CD4 helper T cells play major roles in
shaping immune responses [24, 93]. In vitro and in vivo studies have shown that in AIDS
patients, lymphocyte proliteration in response to defined Ags is reduced. This is referred to
as an anergic state of the immune system [12]. In addition to CD4 T cell depletion, HIV
induces a wide range of impairments in the regulation of immune responses. These include
premature atrophy of the thymus and thymocyte depletion [82], loss of LN architecture, loss
of CD4 T celI function, inversion of CD4/CD8 T-cell ratio, abnormal B celI functions despite
their polyclonal activation and hypergammaglobulinemia, serum auto-Abs and circulating
immune complexes [92, 93, 94]. Also, since cytokines control the homeostasis of the
immune system, their dysregulation in HIV infection contributes to the pathogenesis ot AIDS
[95].
Other defects, in the immune system of HIV infected patients, include a decrease in
memory T cell responses to Ag, poor CTL responses to viral infection and lowered humoral
immune responses to defined Ags [93, 94]. Some studies report a decrease in the
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proportion of Thi cytokines-secreting T-cells in HIV-infected patients while Th2 secreting T
ceNs are increased. MHC-restricted CD8 CTLs, found in large numbers during latent stage
of HIV-1 infection, decrease with disease progression [96]. Since CD4 T ceNs are required
at least partly for CTL activity, their depletion may explain the decline in CTLs as the
disease progresses [93]. Also, since HIV is an intracellular pathogen, its clearance f rom the
organism requires a Thi type cell-mediated immune response in host defense [15, 73].
The ability of HIV-1 to evade the host immune responses leads to the establishment 0f
chronic infection [55]. The viral mechanisms of immune evasion include the following
strategies. The high mutation rate of HIV that allows the virus to evade detection by Ab or T
cells produced in response to viral proteins before mutation. Also, HIV-Nef mediates
selective down-regulation of HLA-A and HLA-B, rendering infected cells undetectable by
CTLs. Concomitantly, the normal cell surface expression of HLA-C and HLA-E allows the
infected cells to evade NK cell-killing as these cells are inhibited by the expression of
HLA-C and —E [55]. Finally, HIV infection preferentially inhibits cell-mediated immunity due
to the immune deviation from Thi to Th2. This immune dysfunction increases the
susceptibility to infection by intracellular pathogens including HIV itself [1]. In fact, since
IFN-y activates and IL-4 inhibits macrophage-mediated killing of intracellular pathogens, the
shift in Th responses may explain the host susceptibility to such microbes [1, 74].
The initial adaptive immune response to HIV infection corresponds to the expansion of
CD8 CTLs specitic for HIV-derived peptides [12, 94]. CD8 T-ceII response to HIV infection
is crucial for antiviral defense through direct destruction of virafly infected cells and/or
through secretion of soluble antiviral molecules [91]. Thus, the partial control of HIV
infection causing the transition of acute infection to the latent phase seems to be due to
CD8 CTLs specific for viral peptides. On the other hand, Abs to a variety of HIV Ags are
secreted by B cells within 6 to 9 weeks after infection. However, the beneficial effect of anti
HIV Ab responses in limiting the disease s questionable [12]. While the most immunogenic
viral proteins in the humoral responses are gp-1 20 and gp-41, anti-envelope-Abs inhibits
poorly viral infectivity [12]. In addition, despite the established role of humoral immune
response in many viral infections, Abs in sera against HIV-1 have only weak neutralizing
activity and are mostly directed against virion debris [92]. However, high level of Abs to HIV
in infected patients suggests an interaction between B cells and activated T ceNs in the
development of immune activity [92]. Moreover, neutralizing Abs able to block the infectivity
of virus may limit the replication of HIV during the asymptomatic stage of infection [93].
1$
HIV infection disrupts cell-mediated and humoral immunity and renders the host susceptible
to CI and maiignancies [12, 93]. Highly active anti-retroviral therapy (HAART) suppresses
viral replication and partially restores CD4 T celi counts, reducing AIDS-related mortality
[12]. Some reports concluded that adaptive immunity is the most critical component of the
immune system for control of H1V infection and that H1V-specific CD4 helper T cells and
CTL responses may decide the rate of disease progression [93, 97].
9.3. DC DEFECTS AND IMPLICATION IN HIV
DCs are the first mucosai cells infected by the virus during oral and sexual transmission and
participate in viral dissemination by transmitting the virus to CD4 T cells [98]. Mucosal DCs
that have been infected process HIV-1 proteins and carry live HIV into the LNs where they
present the viral Ags to T cells. In LNs, HIV-1 replication is the most active and thus DCs
contribute to the efficient propagation of HIV by their migration that is mediated by CCR7
upregulation upon activation [98].
DCs send signais to T cells that promote their ability to replicate the virus [99]. The DC-T
ceN microenvironment is an explosive site for HIV propagation because activated T cells
become highly susceptible to HIV-1 and enhance viral repiication. HIV-1 preferentially
infects CD4 T celis specific for HIV-1 Ags [97]. Viral replication is fast and efficient in
activated T celis and macrophages, partly because cellular factors that positively regulate
viral transcription are abundant in these celis [99]. HIV-infected DCs initiate rounds of T cell
infection by transmitting HIV to resting T ceNs in LNs [92]. Some DCs show latent infection
and become productiveiy infected after maturation. This shift of non-productive to
productive infection is a way for DCs to facilitate the persistence of the virus in the organism
[100]. This is because a productively infected cell produces many virions each capable of
infecting cells and amplifying the infectious cycle [1]. Moreover, in the acute infection, virus
particles are trapped in the FDC network and this is another important mechanism for DCs
to maintain HIV infection over time [94].
DCs are flot only central to the pathogenesis of HIV-1 by serving as initial and continuous
source of the virus, but paradoxically are also essential for the induction of effective anti-HIV
immune responses involving both CD4 and CD8 T cells [92, 97, 101]. Carnage of virus by
DC into LNs allows clustering and priming of T ceils and production of antiviral immune
responses [100]. Therefore, DCs depletion during HIV infection is implicated in HIV-1
pathogenesis by reducing immune system capacity to prime T celis and to generate antiviral
responses. However, the loss of DCs when they become overtly infected imitates H1V
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dissemination [91]. Depletion of HIV infected DCs and T-cells, is due to either direct lysis by
the virus or by HIV-specific CTLs. Also, in AIDS, DC development from CD34 stem cells is
impaired [101]. Thus, DCs disappearance from blood of HIV-1 infected patients could be
caused by various mechanisms. These events include failure of DC precursors to
differentiate, their death due to infection or CTLs and their relocalization into the secondary
Iymphoid tissues after maturation [55].
Since HIV-1-induced maturation of DCs may contribute to their decrease in the blood of
patients with high viral Ioads, this process may have important consequences for HIV-1
cellular transmission and HIV-1-specific T-cefl responses [102]. MDC maturation depends
on the stimuli produced in the local environment by HIV-1 activated pDCs [45]. PDCs’ IFN-a
secretion in response to HIV-1 induces the maturation of bystander CD11c DCs (mDCs in
human). MDCs maturation is characterized by the induction of CD83 and CCR7 expression
and the upregulation of CD8O and CD86 allowing their migration to LN5 and Ag
presentation to T cells [45]. However, it has been reported that the T-cell stimulatory
function of DCs is impaired in HIV infection possibly due to defective co-stimulatory
molecules expression [103]. Accordingly, viral proteins such as Nef and Tat selectively
induce immature DC biology that allows DC-T celI interaction without up-regulation of co
stimulatory molecules for effective priming of T cells [104]. Defects in DCs maturation can
be beneficial to HIV-1 pathogenesis because immature DCs promote the induction of
peripheral tolerance to seif-peptides, and HIV may use this function of DCs to inhibit
immune responses [50]. In addition, IL-12 is a cytokine involved in the initiation of Thi type
of immune responses and its production depends on DC5 maturational state. The altered
production of IL-12 by DCs in HIV-1 infection could be involved in the loss of Thi type
immune responses in HIV [15, 73].
Overali, DC abnormalities are important in the induction of immunosuppression caused by
HIV [96]. The infection of DCs, their depletion and impaired signaling to T cells participates
in shaping the pattern of immune responses in HIV-1 infected individuals. Treatment that
reverses the defects caused by HIV in the DC population may improve cell-mediated
immunity [92].
9.4. PDC DEFECTS AND IMPLICATION IN HIV INFECTION
The preservation of pDCs and mDCs is crucial for shaping anti-HIV immunity [45]. PDCs
expressing CD4, CXCR4 and CCR5 (the major coreceptors of HIV-1) are susceptible to
infection by the virus [32]. It is known that HIV infects pDCs as well as mDCs. But, it is flot
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clear if HIV-1 stimulates pDC through TLRs or after direct entry into the cytoplasm [41, 105].
PDCs respond to HIV-1 infection by producing cytokines such as IFN-a, TNF-o and
chemokines, up-regulating celi surface maturational markers, such as MHCII, CCR7 and
CD83. Thus, HIV-activated pDCs acquire the ability to migrate in response to CCL1 9, which
functions as the ligand for CCR7 and is expressed in Iymphoid organs [60].
Several differences have been reported between pDCs and mDCs in HIV infection. In the
case of intravenous HIV infection, pDCs may be one of the f irst cells to transport virus into
LNs. This is due to pDCs direct access f rom blood to pLNs by trans-HEV migration [56, 64].
Thus, pDCs are involved in rapid trafficking of the virus to LNs where viral spread and
replication are most efficient [45, 60]. In addition, HIV-activated pDC migration to Iymphoid
organs seems necessary for mDC maturation since HIV does not directly activate mDCs,
but seem to be activated by cytokines produced by pDCs [45]. Another difference between
pDC and mDC in HIV infection is that viral replication in pDC requires their activation by
CD4OL, while mDCs replication is independent of CD4OL mediated maturation [106].
Moreover, HIV-activated pDCs acquire the ability to stimulate naïve CD4 T cells, but Iess
efficiently than mDCs probably due to the lower upregulation of costimulatory molecules
[45]. However, both DC subsets can efficiently transmit HIV to T ceNs [45, 97].
Clinical findings support pDCs implication in HIV-1 infection. In fact, the decrease of pDCs
number in the blood of HIV-1-infected individuals correlates with disease severity as for the
reduction in CD4 T celi counts [32]. This depletion of blood IPC in AIDS patients is not due
to a generalized hematopoietic failure. It has been reported that elevated levels of IL-10 as
observed in HIV infection could decrease IFN-a production and the frequency of pDCs
because IFN-a is a survival factor for pDCs [74].
PDCs seem to play a particular role in the resistance to CI during the course of HIV
infection. This is based on many findings that show an increase in pDC number in long-term
non-progressor individuals compared to AIDS-developing patients [107, 108]. Moreover,
during HAART, an increase in pDC frequency is associated with normalization of CD4 T
ceil count, Cl resistance and overall clinically apparent immune reconstitution [108, 109].
Accordingly, one study has reported the existence of a correlation between pDC number
after one month of HAART and viremia after interruption of HAART. In fact, HAART must be
discontinued because of various complications that it induces in treated patients. This
correlation suggests that pDC count can be used as a tool to identify individuals in whom
HAART interruption can be beneficial [110]. Thus, IPC count is used as a new parameter to
monitor the status of the immune system in HIV-infected subjects [11].
21
An important role for 1PCs in immune responses against HIV was f irst suggested, because
of the known inhibitory eftects of 1FN-a on HIV replication [109]. The level of IFN-a is
undetectable in the serum of heaithy individuals while this cytokine is increased in acute
HIV-infection. However, IFN-a production by total PBMCs has been reported to be
decreased during the course of H1V-1 infection [74, 107, 109]. PBMC IFN-a production
correlates with pDC frequency in HIV infection as well as in other diseases [107, 109]. Thus,
defects in IFN-a production are caused by both pDCs depletion and lower production per
celi [32]. The levels of IFN-a in blood during the acute H1V infection correlate with HIV-1
viremia. The progressive decrease of the initially elevated levels of this cytokine coincides
with the reduction of viral load and CD4 T ceils. Paradoxically, IFN-a augmentation at late
stages of AIDS has been associated with poor clinical prognosis [111, 112].
The role of IFN-a in the control of HIV-1 infection is based on diverse antiviral effects of this
cytokine (supplementary figure 10) [69, 80]. The mechanisms of antiviral action of type-l
IFN5 in HIV infection are either direct or indirect due to the induction of infected celi lysis by
NK cells, specific CTLs, or Thi ceils. As previously mentioned in this text, the direct effects
of IFN-a are multiple and include the induction of 1FN-response genes such as MxA, which
decreases HIV-1 replication [69, 80]. HIV-1 induces multiple mechanisms to counteract
these effects. For example, HIV-1 Tat protein inhibits IFN-a-induced PKR activity in infected
cells [80].
The indirect effects of type-l lFNs include the enhancement of pDCs survival, the induction
ot mDCs maturation and monocyte differentiation into efficient APCs [113]. In addition, NK
cell defects in HIV-infection are partly due to IFN-a responsiveness and/or production [112].
in fact, an important part of the innate immune response to HIV-1 is due to NK cells [112].
NK cells produce 1FN-y that helps eliminating HIV-infected cells through antigen-dependent
cytotoxicity. It has been reported that the percentage and the activity of NK cells are
decreased in H1V infection [112, 114]. The reduced NK celI cytotoxicity has been found at
ail stages of HIV infection and this defect is increased during disease progression [12].
Apart f rom NK cells activation, another indirect effect of IFN-a in HIV is due to the promotion
of antiviral Thi immune responses. HIV-infected pDCs have been shown to induce a Thi
polarization of allogeneic CD4 T celi responses partly due to IFN-a mediated iL-12R
upregulation on CD4 helper T cells [41, 60]. Thus, since 1FN-a is involved in Thi immune
responses, pDCs depletion during H1V infection and their repletion post-HAART could
reflect the progressive loss and reconstitution of Thi pathway, respectively [108]
(supplementary figure 12).
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On the other hand, pDCs production of IFN-a in thymus may lead to upregulation of MHCI
on thymocytes, [55]. Such upregulation may limit HIV replication in the thymus by
enhancing the antiviral immunity [74]. However, this response seems not sufficient or
optimal for the control of virus replication in this central lymphoid organ [74]. Paradoxically,
some studies suggest that the enhanced IFN-o production in HIV-infected thymus
participates in the pathogenesis of HIV because it correlates with thymocyte depletion
decreasing T celi generation [55]. Despite many theoretical reports and experimental
findings, the role of IFN-a in H IV-1 infection is flot yet well known. In fact, controversy exists
concerning the beneficial effects of this cytokine because treatment 0f HIV-1 infected
patients with IFN-a generated mixed result [74].
9.5. THE USE 0F CPG ODNS ON HIV INFECTION
Synthetic CpG ODNs induce IFN-o production by pDCs and favor Thl response and ceIl
mediated immunity by CD8 T cells independently of CD4 T ceil help. Since these
parameters are impaired in HIV-1 infection, therapy using CpG appear useful to reverse
these defects [47, 74].
As mentioned in the section on pDCs function, the effect of IFN-a produced by pDCs on
monocytes has important consequences for the generation of immune responses. In fact,
since DCs are at Iow frequency in the organism, the maturation of monocytes into DCs
amplifies total Ag-presenting function of the immune system [7, 47]. Exposure of PBMCs to
CpG ODN leads to decreased expression 0f monocyte marker CD14 and their maturation.
Monocytes derived from HIV-1 infected patients, show an impaired maturation in response
to CpG. It has been demonstrated that reduced IFN-a production and responsiveness
contribute at least in part to defective monocyte maturation in response to CpG [47]. Thus,
the reduced IFN-a production, which correlates with HIV replication and viremia, may
interfere with the efficacy of CpG in HIV-1 infection [47].
10. THE BIOLOGICAL SYSTEM USED FOR THIS STUDY
The model used for this study is the CD4C/HIV transgenic (Tg) mouse on a C3H
background. Either only nef-expressing (CD4C,HIVmUtG) or, expressing nef env and rev
expressing (CD4C/HIVmutj Tg mice, which show an identical phenotype were used for
experimental investigations [115].
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10.1. CD4C/HIV TRANSGENIC (TG) MOUSE DESCRIPTION
In order to obtain a smafl animal model 0f HIV-1 infection, our laboratory generated a Tg
mouse expressing HIV-1 genes (see the section on materials and methods and
supplementary figure 13). In these Tg mice, HIV-1 genes were expressed in the same ceil
subsets as those normally infected by HIV-1 in human. These ceils compromise CD4 T
celis and cells of the DC/macrophages lineage [115, 1 16].
For constructing CD4C/HIV Tg mice, human CD4 gene promoter sequences fused to
mouse CD4 gene enhancer was used to express whole HIV-1 coding sequences [74].
Previous studies showed that the regulatory sequences contained in the CD4C promoter
can direct the specific expression of a gene in CD4CD8 and CD4CD8 thymocytes, as
well as peripheral CD4CD8 T cells, and macrophages [116, 117]. In thîs Tg mouse model,
HIV-1 gene(s) is expressed in ceIl populations that are natural targets of HIV-1 infection in
humans [116]. This paffern of HIV genes expression is pathogenic in mouse and induces a
disease with major hallmarks of AIDS [116]. One study in CD4C/HIV Tg mice revealed that
a relatively hïgh level of viral RNA s required to cause the AIDS-like disease and the
severity of the disease correlates with the level of transgene expression [716]. In order to
examine the implication of individual HIV-genes in the pathogenesis of this disease, several
Tg mice expressing selected H IV-1 genes were generated and the expression of nef was
shown to be required and suificient for disease induction [115].
In the transgene of CD4C/HlVmutG mice, ail HIV-1 genes were rendered non-functional by
mutation except for the nef gene. The transgene in cD4c,HIvm s essentially similar to
CD4C,HIVmUtG with the exception that besides HIV-1 nef gene, it also retains the rev and
envgenesofHlV-1 [115,116].
10.2. AIDS-LIKE DISEASE AND IMMUNE SYSTEM DYSFUNCTIONS IN TG MICE
CD4C/HIV Tg mice develop an AIDS-like syndrome that includes organ diseases; thymus
and LN atrophy together with wasting and premature death [116]. The organ diseases
compromise interstitial nephritis and segmental glomerulosclerosis in kidney, lymphocytic
interstitial pneumonitis in lung and myocytolysis together with myocarditis in heart [116].
The signs and symptoms of AIDS-like disease resemble more closely those observed in
pediatric than aduit AIDS. This is in accordance with the fact that HIV genes in Tg mice are
expressed early in life as it is the case for children with vertically transmitted HIV infection.
The immune system dysfunctions in Tg mice include celi surface CD4 down-regulation, loss
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of thymocytes, depletion of peripheral CD4 T ceils, an increase in B celis and their
activation accompanied by autoantibodies [1 16, 118, 119]. Tg mice similarly to what is
reported in HIV-1 and SIV diseases, show impaired capacity to generate germinal centers
(GC5) following primary immunization with OVA. GCs are central regions of primary tollicles
in lymphoid tissues, which are required for the generation and maintenance of
immunological memory and for B celI affinity maturation [1, 118]. One of the main reasons
of the impaired GC formation in Tg mice is the decrease in CD4OL due to CD4 T celi
depletion and their defective CD4OL production [118].
Previously DCs were studied in CD4C/HIV Tg mice but the technique used for their
purification excluded pDCs [119]. This study reported a decrease in lymphoid DCs and an
accumulation of mDCs in LN. Moreover, spienic DC’s Ag-presenting function was found to
be reduced in accordance with their immature phenotype. AIse, it is known that immature
DCs are not able to prime T cells but are permissive for HIV replication [120]. Therefore,
DCs characteristics in CD4C/HIVmUIG mice suggest a role for Nef in favoring HIV replication
while preventing the production cf efficient antiviral immune respcnses. [119].
7 0.3. HIV-7 PROTEIN NEF
Nef is a 27-35 kilo-dalton (Kda) protein that is common te HIV and SIV [93]. The nef gene is
unique te the primate lentiviruses [physical and functional]. The HIV-1 net gene encodes a
phosphoprotein, detected abundantly in the cytoplasm scon after HIV-1 infects a celI [93].
Nef anchors to the membrane cf infected cells by its myristic acid moiety ccvalently bound
te the N terminus. Despite the initial findings suggesting that Nef suppresses viral gene
expression (hence the name “negative factor”), it is now clear that Nef is important for HIV
pathogenesis [89]. The presence cf Nef deletion in some long terminal non-progresser
patients implies that Nef may play a role in the persistence cf high viral loads in HIV-1
infected patients [89]. In fact, Nef augments viral replication and infectivity through a
combination cf multiple effects. Nef functions are described in the following paragraphs and
include inhibition cf apoptosis, CD4 and MHCI downregulation, modulation cf cellular signal
transduction pathways and stimulation cf virus infectivity [93, 116].
The anti-apoptotic effect cf Nef contributes te the viral persistence by inhibiting the death cf
infected macrophages and DCs that serve as a continuous reservoir for the virus [119]. Nef
as well as Env and Vpu down-regulate CD4; Nef accomplishes this tunction by increasing
the rate cf CD4 internalization from the membrane [121, 122]. CD4 is a type I integral
membrane gp that is required ter T cell maturation and is involved in the activation cf
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mature T helper lymphocytes [1]. CD4 allows the stabilization cf the interaction between the
TCR on T ceils and MHCII complexes on APCs and recruits Lck for efficient transduction of
the TCR signal [1]. Nef down-regulates CD4 from the celi surface in order to prevent the
inhibitory effect of CD4 in viral release from intected celis. In fact, because cf its high affinity
for the glycoproteins of viral membrane, CD4 traps viral envelop interfering with viral release
f rom infected host cells. Other beneficial effects for HIV caused by CD4 down-regulation
include the liberation of Lck that can promote T celi activation, thus favoring viral gene
expression [121, 123]. Nef interacts with Lck tyrosine kinase and impairs both proximal and
distal Lck-mediated signaling events, thus inducing TCR signaling defect, which is involved
in AIDS pathogenesis [124].
A viral strategy to inhibit antiviral T celI responses is due to Nef, which causes MHCI and Il
downregulation on infected cells including APC5 altering their ability to prime T cells [120,
121]. Nef-induced MHCI down-regulation is dependent on a tyrosine found in the
cytoplasmic tails of HLA-A and B, by delaying transport of MHC from the endoplasmic
reticulum fER) to the plasma membrane [80, 122]. Nef does not inhibit the expression of
HLA-C and —E, necessary to protect from NK-cell mediated lysis [122]. As MHCI is
responsible for presenting Ag to CTL, Nef-mediated MHCI down-regulation is part of HIV
evasion mechanisms from host immune responses [123]. However, Nef-mediated removal
of MHC molecules f rom APC’s surface cannot prevent T celI priming. In fact, peptide-loaded
MHC can remain on the celI surface for a short period before its downregulation by Nef,
allowing T cell priming [121]. Recently, it has been reported that Nef also mediates loss of
costimulatory molecules CD8O and CD86 from the APC surface [119]. This effect was
observed in vitro in macrophages and DCs from both human and mouse. Nef promotes in
vivo amplification of infection by inducing cellular pathways of T cell activation [125].
Moreover, HIV-1 Nef can possibly induce conditions required for the entry of the virus into
non-activated cells. For example, in infected macrophages, Nef stimulates the production
of soluble factors that cause T celI susceptibility to HIV entry [99].
11. RATIONALE AND OBJECTIVES 0F THIS STUDY
The aim of this study is to describe the characteristics of pDCs from CD4C/HIV Tg mice,
which develops an AIDS-like disease. The CD4C/HIV-Tg mouse model expressing Nef is a
useful tool to study Net-mediated immune dysfunctions in vivo and Nef contribution in HIV
pathogenesis. The findings in this mouse model can contribute knowledge about the
pathogenesis of human HIV infection. Moreover, since murine pDCs are considered the
equivalent ot the human pDCs due to many common features, mouse models can be used
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to examine pDCs in contexts of microbial infections, tumors, and autoimmune disease [1,
42]. This study focuses on aspects of pDCs functions, which are altered or undetermined in
HIV-infected subjects. An important role for IPCs in immune responses against HIV has
been suggested [109]. In HIV infection, pDCs are reduced in blood and production of IFN-a
is impaired [105, 111]. Defects in IFN-a production seem to be caused by both pDCs
depletion and Iower production per ceIl [41]. Thus, delineation of the role of IPCs and IFN-a
in HIV-1 infection is important for beffer understanding of the pathogenesis of AIDS [105].
The rationale of the present study on pDC s based on previous findings showing immune
dysfunctions including DC impairments in AIDS-Iike disease [119]. This study showed that
the distribution of Iymphoid DCs is different f rom mDCs in Tg mice [1 19]. Indeed, Iymphoid
CD8a DCs are decreased in LN of Tg mice while myeloid CD8a DCs are increased in the
same organ [119]. This difference suggests that DC subpopulations are differentially
affected by HIV-1 genefs) expression in Tg mice [119]. Accordingly, several findings
support the differential effect of HIV-1 on pDCs and mDCs in human [126]. For example,
based on in vitro studies, HIV-1 replication in human immature pDC has been shown to
require CD4OL, while HIV-1 replication in mDC can proceed without CD4OL-induced
maturation [106]. However, DCs studied in this model did flot include pDCs, since DCs
identified as CD11cMHCII celis were negatively selected and purified from Iymphoid
organs using anti-B220 Ab in order to eliminate B ceils. This purification technique exciudes
pDCs, because they express B220 and Iow amount of CD1 1c and MHCII [119].
In addition, HIV-1 infection affects the innate immune system [107, 112]. IFN-a produced by
pDCs contributes to innate immune responses in HIV infection because it directly inhibits
viral replication in infected celis and stimulates APC5 as weII as NK ceils as described
previously. Thus, the decrease in IFN-a during the course of HIV infection participates in the
reduction of an innate immune response against the virus. Parallely, since NK celis play a
major role in innate immune responses, the quantitative defect of NK ceNs and their
diminished function during HIV-1 infection, which are partly due to the decrease in IFN-a,
are parameters involved in the suppression of innate immunity in HIV-1 infection. However,
the cHnical significance of innate immunity suppression is flot weII known [107, 112]. In this
model, since the viral protein is present in the organism trom the embryo stage, the innate
immune system could be dysfunctional and may participate in the pathogenesis of AIDS-Iike
disease. The study of pDC as a ceil type with major roles in innate immunity can help to
reveal this potential impairment of innate immunity in Tg mice.
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The objectives of this study is based on previous findings on cDCs alterations in CD4C/HIV
Tg mice as well as on various defects cf pDCs observed in human HI V-infection. Thus, the
expression of the transgene in HIV-Tg mice derived pDCs as well as their frequency,
distribution, maturational state, Iocalization, in vitro survival and response to immuno
stimulants were examined. In addition, preliminary resuits were obtained on pDC IFN-Œ
content and their expansion and maturation in the presence of FIt3L.
The frequency and number cf pDCs in blood and lymphoid organs were measured because
of the clinical reports on AIDS patients correlating these parameters with disease
progression [32]. Alterations in distribution and/or Iocalization of pDCs could resuit f rom
impaired migrational behavior. PDC homing is crucial for their appropriate function and
affects the outcome of the host immune response. CD4C/HIV Tg mouse model is useful for
examining pDC homing in the presence of HIV protein Nef because the study of pDC
Iocalization in HIV-infected humans is flot feasible. In addition, since pDC phenotype and
response to stimulants reflect their state of differentiation and their functions, the study cf
these features provides information about pDCs potential implication in the immune
dysfunction of CD4C/HIV Tg mice. For example, since IFN-Œ is crucial for mDCs
maturation, the alteration in the production of IFN-u may contributes to mDCs immature
phenotype observed in Tg mice [119].
The future work should address questions concerning the effect of pDCs stimulation,
expansion and/or depletion on AIDS-Iike disease by injecting CpG-ODN, Flt3L and/or
depleting Abs to pDC into Tg and control nTg mice, respectively. To study pDCs responses
to in vivo CpG stimulation, pDCs IFN-a production and morphology changes upon
maturation could be measured. Furthermore, in order to directly evaluate the implication of
IFN-a in the development of AIDS-like disease, IFNAR-knockout X CD4C/HIV-double Tg
mice can be generated and examined for the development of the disease.
Finally, the exploration of molecular mechanisms will be useful in explaining pDCs
characteristics in CD4CIHIV Tg mouse model. lndeed, although the ability of pDCs to
secrete type I IFNs in response to viruses is known, the signaling events that lead to type I
IFN secretion have not yet been elucidated [85]. Thus, the level of expression of molecules
such as IRF7, IRF3, STAT3 and Mx proteins could be determined because these molecules
are involved in IFN-a signaling pathway and DC maturation [6].
CHAPTER 2: MATERIALS AND METHODS
7. MICE
CD4C/HIVmUtG transgene was constructed by fusing 14.4 kbp CD4C promoter (Hanna et al.,
1994) to 8.8 kbp BssHlI-SacI fragment of HIV-1 NL4-3,l which was mutated in aN genes
except the nef gene, and the simian virus 40 polyadenylation sequences. The CD4C
promoter consists of 12.5 kbp upstream sequences cf human CD4 gene containing 2.6 kbp
cf 5’ upstream sequences, exon 1, intron 1 and few bases at the beginning cf exon 2, as
wefl as the 1.9 kbp mouse CD4 enhancer at the 5’ end (Hanna et al., 1998a; Hanna et al.,
1998b). cD4c/HIvm transgene is essentially similar to CD4C/HIVmUtG with the exception
that besides HIV-1 nef gene it also retains the rev and env genes of HIV-1 [115]
(supplementary figure 12). Sex-matched littermates were used between 6 and 10 weeks cf
age, because the complete DC system required for adaptive immunity in the mouse is net
fully developed until 5 weeks cf age [127].
The presence cf the transgene was confirmed by Southern blot hybridization cf tau DNA
with 32P-labeled total HIV-1 sequences as a probe, as described previously [115]. The Tg
mice and their non-Tg littermates were housed in the same cages.
2. ANTIBODIES AND REAGENTS
The following antibodies have been used: Rat monoclonal (MC) anti-mouse IFN-a which
reacts with and neutralizes IFN-a 1, 2, 4, 5(p), 6(T) and A isotypes, goat anti-mouse lgM
FITC, rat MC anti-mouse CD4-PE and CD4-APC, rat MC anti-mouse CD8-PE, mouse anti
mouse thyl .2-FITC (CD9O), rat antimouse CD1 1 b-PE, rat anti-mouse CD86-FITC (B7-2),
mouse anti-mouse MC lAk (MHC Class 11)-PE, rat MC anti-mouse CD25-biotin, hamster
MC anti-mouse TCRaIf3-FITC and anti-mouse Ly49Q-FITC were purchased from Cederlane
Technical. The antibodies 30H12 (anti-thyl .2) was obtained f rom Ledbetter and Herzenberg
(Immunol. Rev. 47: 63-90, 1979), purified rat anti-mouse CD19 (MC), rat MC anti-mouse
CD45R/B220-pe-CY5, rat MC anti CD45R/B220-APC, strepavidin PE-CY7, hamster MC
anti-mouse CD1 lc (integrin a chain)-biotin-conjugated, hamster MC anti-mouse CD3-FITC
and hamster MC anti-mouse CD69-FITC were purchased from BD Pharmingen.
Recombinant mouse IL-3 was f rom R and D Systems. Goat IgM-Texas Red was from
Southern Biotechnology Associates (Birmingham, Ala.). Irrelevant rat IgG2a, and rat IgG2b
29
monoclonal antibodies were used for isotype controls. The generation of the soluble CD8a-
CD40L (ligand) has been reported previously [128]. Granulocyte-macrophage colony
stimulating factor (GM-CSF) was from X63-mGM-CSF-transfected plasmacytomas [129].
Oligonucleotides containing a fully phosphorothioated CpG motif, called 20620, is a C-Class
oligo and was a gift f rom Dr Arthur M.Kreig (Coley Pharmaceutical Group) and used at 5
ig/ml after titration and as suggested by the sender.
Mouse FIt3L cDNA was previously cloned in our laboratory in pcDNA3 vector containing
puromycin selection marker (supplementay figure 14.B). 293T cells were transiently
transfected with 10 pg of Flt3L cDNA using the calcium phosphate precipitation method
[130]. Supernatant was collected 48h later, aliquoted and frozen until use. The same 293T
cells were also transfected with an empty plasmid (containing no insert) as control. The
supernatant obtained f rom culture of these cells in the same conditions were used as a
negative control and pDC generation was measured by FACS (see supplementary figure
13.B)
3. PURIFICATION 0F PDC FROM SPLEEN AND LYMPH NODES
To purify pDCs, we employed isolation and enrichment procedures similar to those used to
purify mouse DC [119]. Briefly, spleens were meshed and single ceil suspension was
prepared. This was followed by rad blood ceil (RBC) lysis by resuspending pelleted ceils in
5 ml of Gey’s solution for 5 minutes. Ceil suspensions from subcutaneous LN were
prepared followed by mild enzymatic digestion with collagenase type 4 (Worthington 4188)
at 8mg/ml and DNase I (Sigma DN25) at 1 Omg/ml. Ceil suspensions from 3 or 6 mice were
pooled from either spleen or LN and light-density cells were selected using a percoll
gradient. Contaminant cells were removed by either immunomagnetic bead depletion or
during FACS analysis by gating out of CD19 and Thy1.2 or lgM cells [50, 119] (figure
1 .A). AIl these steps of purification were done under sterile conditions if celis were to be put
in culture.
4. GENERATION 0F BONE MARROW-DERIVED PDC
DCs were derived from BM culture with the use of advanced method of BM-derived DC
(BMDDC) enrichment [131]. Precisely, BM-derived cell suspension was obtained by flushing
the femurs and tibias of mice sterilely. Total cells were seeded at 2 X 106 per 100 mm Petri
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dish (Falcon) in 10 ml cf medium. The medium used was RPMI-1640 (Gibco-BRL, Lite
Technologies) supplemented with 10% inactivated fetal bovine serum (CanSera, Rexdale,
Ontario), L-glutamine (Gibco-BRL), 2-mercaptoethanol, and antibiotics. Supernatant f rom
X63-mGM-CSF ceils was added at final dilution cf 10% (=2Ong/ml). At day 3, 6 and 8 half of
the culture supernatant was collected, centrifuged and cell pellets were resuspended in
fresh media (the same as described above), and added to the culture (see supplementary
figure 13.A for FACS results on non-adherent ceNs at day 10). At day 10 post-enrichment,
non-adherent cells were collected (refered to post-enrichment in Table-Il) by gentle
pipetting, centrifuged and resuspended in the same type of media but in different conditions
for furiher maturation. Stimulated conditions (See results table-II) contained 5% GM-CSF,
5% CD8a-CD4OL and 0.lng/ml of rlL-3, whereas in medium alone (MA) no cytokine was
added [50]. Following over-night O.N. culture, non-adherent fraction of ceNs was obtained
and determined to be DCs (CD1 1c) including pDCs by FACS.
For FIt3L enrichment cf BM-derived cells, 1 X 106 cells per ml were seeded in a 60 mm petri
plates in a total volume of 5 ml medium. The medium was the same as described above
supplemented with Hepes buffer. Supernatant containing FIt3L was added at 20%
concentration ratio te the media. Titration of this supernatant compared to commercial Flt3L
reveald that the concentration used in BM cultures correspond to 35 to 40 ng/ml [46]. Every
3—4 days, 2.5 ml of medium was replaced with f resh medium and Flt3L, as in advanced
method mentioned above. At day 9, further maturation was done O.N.; half of the culture
was further matured with CpG (at 5 jig/ml) and the other half was used as MA [50]. A
second petri was prepared at day O and collected at day 9 and examined as post-Flt3L
enrichment.
5. IMMUNOFLUORESCENCE
Mouse organs were embedded in OCT compound, f rozen in isopentane and stored at
-80°C. Serial cryosections were prepared, fixed in 95% acetone at -20°C for 20 mm, dried at
room temperature, and stored at -20°C until further analysis. For immunolabeling, sections
were rehydrated in PBS (Lite Technology), blocked with PBS + 20% FCS1 and then
sequentially incubated with primary and secondary antibodies in a humidified dark chamber.
Slides were mounted with vectashield aqueous solution (Vector Laboratories, Inc.
Burlingame, CA), and analysis was performed by either confocal microscopy (Zeiss LSM
510) or with a Zeiss Axiovert Si 00 TV microscope [119].
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intracellular IHC was pertormed on cytospins of freshly sorted pDCs from spleen of 6
pooled Tg and 6 pooied non-Tg mice as described previousiy. The ceHs were permeabilized
by 0.05% saponin in PBS solution prior to blocking and staining. Ail steps of IHC were
perormed using 0.05% saponin in PBS solution.
6. QUANT1TATION 0F PDCS BY IMAGE ANALYS1S
Serial cryosections of LNs and spleen from non-Tg (n = 6) and Tg (n = 6) mice 2 to 5
months of age were prepared and labeled with biotinylated anti-CD11c MC Ab
(Pharmingen) and B220-FITC foiiowed by streptavidin-Alexafluor 488-conjugate (Molecular
Probes). Siides were mounted with Vectashield solution. Sections were scanned and color
images were captured with a Zeiss Axiovert S100TV or confocal microscope (Zeiss
LSM51O). Analysis was done with Northern Eclipse 6.0 software and LSM browser
respectively. PDCs were visualized as yellow celis by superimposing images taken in red
with the same image in green (CD11cB220). For study of lymph nodes, images of two
LNs per animal were taken in the cortical and paracortical zones (mean of ten images by
40x objective per animal). For studies of the spleen, images were taken in the white pulp
(mean of ten images by 40x objective per animai). in the spleen, one T zone was visualized
per field. The nonspecific background labeling was subtracted prior to data acquisition.
Quantitation of the area taken up by yellow fluorescent ceils (square micrometers) was
calcuiated and compared between non-Tg and Tg mice [1 19].
7. FLOW CYTOMETRY
Immunolabeling was per[ormed on ice in FACS buffer (lx PBS, 1% bovine serum albumin,
and 0.01% sodium azide), and fluorescence intensity was analyzed with a FACScan
apparatus (Becton Dickinson, San Jose, Calif.). Blood sampie for FACS analysis was
obtained from retro-orbital vein using a heparinized capiilary. Blood was collected in a
ependorfl tube containing 30 tL of EDTA (5mM) in PBS for each capiliary added. This was
followed with RBC lysis and stained as other samples.
8. IN SITU HIBRIDIZATION (1SH)
1SH is the ceilular localization of specific nucleic acid sequences (DNA or RNA), using a
iabeled complementay strand. This technique was performed on cytospins of freshly
isolated sorted cells, using 35S-UTP-labeled antisense and control sense ANA probes as
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described previousiy [116]. Celis from non-Tg control animais hybridized with antisense
probes, as weii as Tg animai tissues hybridized with sense probes, faiied to exhibit any
specific hybridization signai.
9. GIEMSA STAINING 0F PURIFIED PDC
For cytologicai anaiysis, cytospins of freshly isolated FACS-purified CD1 1 cb0B220+ celis
were prepared (500 g, 5 mm), air dried, fixed in methanoi and stained f irst with May
Grunwald and subsequentiy with Giemsa soiution [32, 50].
10. CYTOKINES AND STIMULANTS 0F PERIPHERAL PDCS
Ceii suspensions f rom 3 or 6 mice were pooied from either spieen or LN and iight-density
celis were selected using a percoii gradient under sterile conditions. The recovered ceiis
from pLN and spieen were matured for 24 hours foliowing the same conditions as for BM
described above [11, 50]. Stimuiated conditions contained 5% GM-CSF, 5% CD8a-CD4OL
and 0.lng/mI of riL-3, whereas in medium aione (MA) no cytokine was added [50].
11. FETAL LIVER CELL TRANSPLANTATION: CHIMERA MOUSE MODEL
Congeic strains of mice that differ at the CD45 (common ieukocyte Ag) iocus were used to
construct transpiantation chimera mouse modei. MC Abs specific for the two aiielic variants
of the CD45 moiecule can identify ceiis derived from different donors. Since this Ag is
expressed on ah nucleated biood ceils, CD45 is a genetic marker for foilowing the progeny
of transplanted fetai iiver cehis. Transpiantation of fetai hiver ceNs, similariy to BM ceiis,
estabhishes hematopoiesis driven ceNs by geneticaiiy marked ceiis in the irradiated recipient
mouse [132].
This Table shows the breedings for the generation of embryos used as donors
. CD4C,HlVmtG Beeding C3H, nTg,
Breeding
Tg, CD45.2 CD45.1
C3H, nTg, Tg, C3H, nTg, nTg,
nTg, CD45.2 CD45.2 nTg, CD45.1, CD45.1,
CD45.2 CD45.2+ CD45.2 CD45.2
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Donors: Fetal livers trom 14.5 day old embryos (E14.5) coming from the tollowing breedings
[(nTg (C3H, CD45.1) x nTg (C3H, CD45.2j, and (Tg (CD4C/HIVMutG, C3H CD45.2) x
nTg (C3H, CD45.2)] were harvested. Single celI suspension was made in HBSS
supplemented with 10% FBS, under sterile conditions, with a syringe plunger. CeIl
suspension was filtered through a Nytex mesh (BSH Thompson, Montreal). Remaining fetal
tissue was typed for transgene expression by PCR. When typing was known, the following
mixes were prepared [A: HIV Tg (C3H, CD45.2,50%) mixed with nTg (C3H, CD45.1
CD45.2, 50%) and B: nTg (C3H, CD45.2, 50%) plus nTg (C3H, CD45.2 CD45.1, 50%)].
After one wash, cells were counted (REC ceil lysis was pertormed in the counting aliquot).
CeIls were then resuspended in HBSS solution supplemented with 2% FBS at a
concentration of 20x106 cells per mL.
Hosts: C3H/HeN (CD45.2) hosts (8 to 12 week-old) were lethally irradiated (950 Rads)
using Mark l-68A1 Irradiator (Cs-137, J.L. Shepherds & Associates). Hosts were injected,
via the tail vein, with 4x1 06 fetal liver ceils in 0.2 mL of HBSS solution supplemented with
2% FBS 4-6 hours after irradiation. Hosts were assayed 2 to 3 months after transplantation
[133].
12. PCR TECHNIQUE FOR TRANSGENE DETECTION
A piece of tetal tissu was placed in 200 pL of lysis buffer (0.1M NaCI, 0.O1M EDTA,
0.05M Tris pH 7.5, 0.5% Nonidet 40 and 0.05% ot Tween 20) supplemented with 10 L ot
proteinase K (10 mg/mL) and digested at 55°C for 20 min. to 2 hours. After digestion,
lysates were centrifuged to pellet non-digested tissue and 100 pL of supernatant was
taken. This aliquot was heated at 100°C for 8 mm, further diluted (10 pL in 200 pL of
water) and further heated at 55°C for 30 minutes. PCR reaction was performed with nef
specific primers (sense primer: CATGGAGCAATCACAAGTAG, antisense primer:
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GGTACTAGCHGAAGCACCA). Detection of the mouse myb gene using sense primer:
CCAGTCACGHCCCTATCCT and an anti-sense primer:GCCTGCTGTCCCHCAGCTC
was done as a control. The PCR was performed under the following conditions (40
seconds at 94°C, 1 minute at 54°C, 30 seconds at 72°C for 1 cycle, followed by 40
seconds at 94°C, 45 seconds at 54°C, by 1 minute at 72°C for a total of 24 cycles was
performed.
12. STATISTICS
Statistical analysis of resuits was done with twotailed Student’s t test. P values of <0.05
were considered significant. Data are means ± standard deviation (SD).
CHAPTER 3: RESULTS
1. IDENTIFICATION AND MORPHOLOGY 0F PDC FROM LYMPHOID ORGANS: TG MICE
DERIVED PLN PDC EXPRESS HIGHER LEVEL 0F CD1JC ON THEIR SURFACE AND
DISPLAY UNUSUAL LIGHT SCATTER FACS PARAMETERS COMPARED TO THEIR
EQUIVALENTS FROM NTG MICE. THESE CHARACTERISTICS ARE SIMILAR
BETWEEN TG AND NTG MICE-DERIVED SPLENIC PDC.
In order to identify pDC in secondary Iymphoid organs, total pLN-derived ceils as well as
spienocytes have been used for DC enrichment as mentioned in the section on materials
and methods. Mice were used between the ages of 6 to 70 weeks because the complete
DC system required for adaptive immunity in the mouse is not fully developed until 5 weeks
of age [127]. DC-enriched ceil-suspensions were stained with multiple Abs against cell
surface markers of pDCs allowing their identification by the use of multicolor fluorescence
activated celI sorter (FACS). As shown in figure 1A.b PDCs were defined as
CD11cI0tB220igM celis among live ceils. An Ab against lgM was used in order to exclude
contaminant B ceils that have not been eliminated by DC enrichment technique (Figure
1A.a). Also, the exclusion of contaminant B cells, which share with pDCs the expression of
5220 with other markers such as CD19, was less efficient for pDC population identification
by FACS (figure 1A.c).
In terms of light scatter characteristics that are indicators of celi size (FSC) and cell
granularity (SSC), pDC show the expected FACS profiles consistent with their reported
morphotogy resembling plasma cells [38]. As observed in figure 1 B, pDCs correspond to
intermediate to large size cells with low granularity that is representative of their round
shape and absence of dendrites. Accordingly, Giemsa staining of freshly sorted splenic
pDCs shows no difference in the morphology of Tg-derived and nTg-derived pDCs (figure
1C).
In contrast to splenic pDCs shown in figure lB, pLN-derived pDCs from Tg mice express
higher levels of CD1 1 c than their equivalents from nTg mice (figure 1 D). Moreover, CD1 1 c
pDCs (green dots) observed among Tg pLNs-derived cells show an unusual light-scaffer
pattern with a wide range of SSC, reaching higher levels than CD1 1 dbO pDCs (purple dots).
This could be indicative of the presence of dendrites on CD1 1 c pDCs, which correspond to
cells at a more mature stage of development than CDlldb0 pDCs. Since the stage of
maturation of pDCs is associated with their function [50], the shift in CD1 1 c expression of
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pLN-derived pDCs may be due to a functional change in pDC population in Tg mice pLNs,
which is the site where the immune response is induced.
FIGURE 1: PDC IDENTIFICATION AND MORPHOLOGY
Figure LA: PDC identification by FACS
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Figure 1.8: Splenic pDCs light scatter characteristics by FACS
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Figure 1.D: PLNs pDC light scatter characteristics by FACS
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FIGURE 1. PDC identification and morphology
A) In ail experiments in this study examining pDCs from peripheral Iymphoid organs, celI
suspensions were prepared from spleen or pLNs of a pool of 3 to 6 Tg and non-Tg,
sex- and age-matched littermate mice and enriched for DCs as described in
materials and methods. Contaminant B cells that have remained in DC-enriched ceil
suspensions after percoll separation are represented by CD1 1 cE220 ceils shown in
figure 1 .A.a. These ceils were eliminated du ring FACS analysis since they were
identified by the use of different B ceil makers apart from B220 expressed on pDCs
[50]. After gating on live celis, which do not stain with propidium iodide (PI), a marker
of dead cells, 1gW cells were eliminated by gating and among IgM ceNs pDCs were
identified as CD1 1 cb0B220+ while cDCs were defined as CD1 1 chiB22OE cells (figure
1.A.b.). It should be noted that cDCs include CD11bCD8a lymphoid and
CD1 1 bCD8a myeloid DCs. The FACS panels in a, b and c in figure 1 .A. correspond
to FACS analysîs in which B celis were not gated out, 1gW cells were gated out and
CD19thy1.2 cells were gated out respectively. Comparing the presence of
contaminant B celis in figures 1 .A. a, b and c allows visualizing that the least
contaminant B cells is obtained when lgM co-staining is used to distinguish pDCs
f rom B celis.
B) This figure shows FACS panels on splenic pDCs derived from both Tg and nTg mice
in order to reveal their light scaffer characteristics. While blue dots correspond to
cDCs with a wide range and reaching higher levels of SSC and FSC values, purpie
dots correspond to pDCs with lower SSC values and more homogeneous FSC
values than blue dots (cDCs).
C) Freshly sorted spienic pDCs identified as CD1 1 cb0h1 B220lgM ceNs (as shown in
figure 1 .A.b.) were cytospined and stained with Giemsa in order to visualize their
morphology. Images from Tg and nTg derived pDCs show their round morphology
lacking dendrites and an eccentric and large nucleus.
D) This figure shows FACS panels on pLNs pDCs derived from both Tg and nTg mice
and reveals their light scatter characteristics. In Tg mice pDCs show a shift to higher
expression of CD1 1 c compared to nTg as reported by mean fluorescence intensity
(MFI) of CD11c expression. These CDllchI pDCs (green dots) possess higher SSC
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values than CDllcb0 pDCs (purpie dots), mimicking cDCs (blue dots) light scatter
pattern since SSC mean values of CD1 1 chi pDCs is doser to cDCs than to CD1 1 do
pDCs.
2. THE BIOLOGICAL SYSTEM
CD4C/HIV Tg mice develop a severe AIDS-like disease characterized by the progressive
loss of CD4 T cells [116]. In figure 2, some of the clinical features of these Tg mice can be
observed. The clinical observations of CD4C/HIV Tg mice include hypoactivity, lower body
size and weight, ruffled haïr and curved back when compared to normal mice. At autopsy,
macroscopically observed signs compromise spenomegaly with a dark color and irregular
surface spleen as well as shrunk and pale kidney with granular surface [116]. 0D40,HlVmutA
Tg mice express rev env and nef genes of HIV-1 and their phenotype is the same as
CD4C,HIVmUIG, which express nef only. Both of these Tg mice develop the same AIDS-like
disease with similar course as described in the introduction.
FIGURE 2: THE BIOLOGICAL SYSTEM
FIGURE 2.
CD4C/HlVmutG Tg mice appearance is compared to nTg mice. In the upper panels, some
of their clinical abnormalities such as the lower body size, ruffled hair and curved back
can be observed. The lower panels show macroscopic signs of the AIDS-like disease
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including dark color and irregular surface spleen as well as shrunk and pale kidney with
granular surface.
3. TRANSGENE EXPRESSION IN PDC: A MAJOR PROPORTION 0F PDCS IN
CD4C/HIV TRANSGENIC MICE EXPRESS NEF.
It has been reported that DCs from CD4C,HIVmutP express the Tg but the technique used for
DC purification in this model excluded pDCs [119], and therefore no information is available
on pDCs transgene expression. In order to be consistent with this previous study on DCs,
CD4C,HIVmutP mice were used to assess Tg expression on pDCs. The transgene
expression on pDCs was examined by three different techniques. The transgene was
detected by in situ hybridization (ISH) (Figure 3A) as weII as immunohistochemistry (IHC)
(Figure 3C) on sorted splenic pDCs. Transgene positive celis were counted on slides f rom
ISH and the compiled results show that 50 to 60% of spienic pDCs express the Tg (Figure
3E). Moreover, on a per-ceIl basis, moderate expression of the transgene was detected on
pDCs compared to high expressing thymocytes by counting the number of silver grain
deposits on positive cells.
In addition, transgene expression on pDCs was measured by a direct technique using
CD4C/GFP-Nef X CD4C/HIVmUtG double Tg mice were used. Since green fluorescent
protein (GFP)-Nef Tg mice express low levels of Nef and do not develop an AIDS-like
disease, this mouse model cannot be used for retracing Nef-expressing cells in a diseased
organism. In order to obtain a mouse model developing the AIDS-like disease and
concomitantly allowing the detection of Nef expression by FACS based on GFP co
expression, CD4C/GFP-Nef mice were bred with CD4C,HIVmUtG mice and double Tg
CD4C/GFP-Nef X CD4C,HIVmtG mice were produced in our laboratory. These double Tg
mice develop an AIDS-Iike disease and allow the delineation of Nef expressing cells. FACS
analysis on pDCs derived f rom these mice show that 40% of splenic and 25% cf pLNs
pDCs expressed GFP (figure 3D). Based on these findings the level of transgene
expression by pDCs in pLN is lower compared to pDCs in spleen.
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FIGURE 3: TRANSGENE EXPRESSION IN PDC
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FIGURE 3. Tg expression in pDC
A) ISH technique was per[ormed on freshiy sorted spienic pDCs based on their
identification as described in figure 1.B. After cytospin, sorted pDCs were examined for
transgene expression by ISH with 35S-Iabeled HIV-1-specific anti-sense and control
sense riboprobes [116]. Sorted thymocytes were used as a positive control as they are
known to express high levels of the transgene [116]. PDCs from nTg animais hybridized
with antisense probes, as weil as Tg mice-derived pDCs hybridized with sense probes,
failed to exhibit any specitic hybridization signal. The number of experiment for 1SH as
weil as for IHC was 1. The experiment was done on spienic pDCs derived from a pool of
3 sex- and age-matched Tg (CD4C/HIVmutA) and non-Tg littermates.
B) ISH resuits were compiied by a ceil count done on 600 ceiis and the results are
shown in the graph. Ceils with 2 or more silver grains were considered as transgene
positive ceiis since based on previous experiments with this technique unspecific
labeling can be exciuded in this way.
C) 1HC were performed on freshiy sorted cytospined spienic pDCs stained with an anti-
Nef Ab. Thymocytes were stained as a positive controi as they are known to express
high levels of the transgene [116]. Staining with isotypic control Ab. was done on both Tg
and nTg pDCs to show non-specific binding.
D) FACS analysis was done on DC-enriched ceii suspension derived from lymphoid
organs of CD4C/GFP-Nef X CD4C/HlVmutG double transgenic mice. Nef-expressing
pDCs correspond to GFP cells among total pDC population identified as described in
figure 1 .B. The graph shows the compilation of results obtained from 2 independent
experiments. The variation in the percentage values of GFP pDCs between the two
experiments is shown as SD represented by y-axis error bars.
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4. PDCS FREQUENCY, DISTRIBUTION, PHENOTYPE AND IN VITRO SURVIVAL: IN
CD4C/HIV TG MICE, PDC FREQUENCY IS INCREASED IN THE SPLEEN AND
REDUCED IN PLN AND THEIR IN VITRO SURVIVAL AS WELL AS THEIR PHENOTYPE
IS ABNORMAL
4.7. FREQUENCY AND DISTRIBUTION
Spienic pDCs absolute ceil number as well as percentage is significantly increased whiie
pLNs-derived pDCs are diminished in Tg mice (Table I). Therefore, pDCs distribution is
abnormal in Tg mice. PDCs higher frequency in spleen in this model is similar to the
increase observed in mice soon after viral challenge (MCMV) corresponding to the time cf
maximal IFN-a production [34]. For data obtained on pLNs-derived pDCs, it should be taken
into consideration that pLNs in Tg mice are atrophic and the total ceil number is significantly
reduced compared to pLNs from normal mice [116].
Blood pDCs are different from pDCs derived from ail lymphoid tissues since they are
principaily composed of CD4CD8 subpopulation [50]. As mentioned in the introduction,
blood pDCs are immature precursors of pDCs residing in lymphoid tissues and based on
FACS resuits, the percentage of blood pDCs is about 2 folds higher in Tg mice (Figure 4).
This resuit could partly explain pDCs augmentation in spleen as they may be increased in
the red pulp. However, experiments visualizing pDCs in the red pulp are necessary to
confirm this hypothesis.
4.2. IN VITRO SURVIVAL
It is known that DCs die rapidly in culture in MA while granulocyte-macrophage colony
stimulating factor (GM-CSF), and/or rlL-3 enhance their survival [1, 50]. CD4OL is a
maturational stimulus for pDCs [57]. The response of splenic pDCs to a combination of
immuno-stimulants was examined in terms of their survivai. For this, the absolute cell
number as well as the frequency of pDCs was compared between two culture conditions,
stimulated and MA (table II). While nlg mice-derived splenic pDCs show a slightly higher
survivai in terms of absolute celi number in stimulated condition compared to MA, Tg pDCs
survive less in response to in vitro stimulation than te MA. Based on these data, Tg pDCs
show a defective survival response to immunostimulants in vitro.
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4.3. PHENOTYPE
CD4 and CD8 expression on pDCs is used to distinguish four functionally distinct
subpopulations [50]. The expression of these markers were measured on pDCs derived
from peripheral lymphoid organs of both Tg and nTg mice. As shown in figure 5A and 5B,
the expression of CD4 is drastically decreased on Tg pDCs compared to nTg pDCs derived
f rom both pLNs and spleen. This decrease is observed as well in the percentage of pDCs
expressing CD4 as in their level of cell surtace expression of CD4 as reflected by MFI
values. The expression of CD8 (percentage and MFI) is also decreased in Tg-derived pDCs
compared to nTg-derived pDCs, but to a lesser extent than CD4.
TABLE I: PDCS FREQUENCY AND DISTRIBUTION IN LYMPHOID ORGANS
EX VIVO PDC
SPLEEN % #X105
nTg 3.08±0.26 1.2±0.05
Tg 5.23 ± 0.38 4.8 ± 0.04
PLN % #X104
nTg 1.38±0.06 3.03±0.63
Tg 0.62 ± 0.09 0.24 ± 0.09
TABLE-I: PDCs were identified as described in figure 1 .B. and recovered from
peripheral Iymphoid organs. The purification technique included DC enrichment and
sort by FACS as described in materials and methods. The percentage and absolute
number of cells were assessed by FACS analysis of sorted cells and cell count by
the technique of blue trypan exclusion of dead cells, respectively. The number of
experiments was at least 3. In each experiment, pDCs were derived f rom a pool of 3
to 6 Tg (CD4C,HIVmLtj and nTg sex- and age-matched littermate mice between 6 to
10 weeks old. Data are shown as mean values ± SD between different experiments.
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TABLE II: PDC IN VITRO SURVIVAL
Spleen: post-culture PDC
Medium alone (MA) % # X 10
nTg 6.6 ± 0.5 0.5 ± 0.007
Tg 5.1 ± 0.2 1 ± 0.01
Stimulated % #X105
nTg 5.75±1.3 1.2±0.4
Tg 4.2 ± 0.2 0.4 ± 0.3
Stimulated/MA % #X105
nlg 1.17±0.18 2.4±0.8
Tg 0.82 ± 0.07 0.38 ±0.26
TABLE-II: For survival assays, ceil suspensions from spleen enriched for DCs were
prepared as described in Table I but celis were not sorted. NTg and Tg
(CD4C,HlVmj mice-derîved ceil preparations were seeded at a concentration of 0.5
to 1 million ceils per ml in Falcon Petri dishes. CeNs were recuperated after 24 hours,
counted and prepared for FACS analysis. Ceil culture in MA was used as a base-une
control for stimulated condition. Stimulation refers to the addition of GM-CSF, CD4OL
and rlL3 to the same media used in MA. PDCs and cDCs absolute ceil number and
percentage were parameters measured to assess their survival. The response to
immunostimulants is represented by the ratio of percentage or absolute celi number
in stimulated condition to MA.
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FACS analysis was performed on blood extracted from intraocular vein after the removal
of red blood cells as described in materials and methods. LY49Q and B220 co-staining
were used to identify pDCs, since in the periphery Ly49Q is expressed on pDCs but not
on NK cells [51]. Also, LY49QB22O cells correspond to pDCs because Gr1IY49Q
ceils other than pDCs do not express B220 in mouse peripheral blood [51]. Results
shown in figure 4 are the compilation of data obtained from 2 independent experiments
and in each experiment 2 Tg (CD4C/HIVmUtG) and 2 nTg sex- and age-matched littermate
mice have been used separately. In this graph mean values of the 2 Tg mice and 2 nTg
mice are reported and y-axis error bars represent the SD between the 2 experiments.
FIGURE 4: PDC FREQUENCY IN BLOOD
PDG frequency in blood (LY49Q+ B220+ celis)
nTg Tg
FIGURE 4.
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(N FIGURE 5: PHENOTYPE
5.A: pLN pDC phenotype
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5.B: Splenic pDC phenotype
nTg pDC Tg pDC
60 60 Ih
38%,42 9Ç,,16
30 1R13
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FIGURE 5: PHENOTYPE
FACS analysis was done on DC-enriched celI suspensions f rom lymphoid organs
prepared as described in table II. Two lymphoid organs, pLNs (A) and spleen (B) were
examined in this experiment. PDCs and cDCs were defined as CD11cI0B22O+lgM and
CD1 1 chIB22OlgM cells as described in figure 1 .B. Histograms show the expression of
each marker on gated pDCs and cDCs. The doted unes correspond to the isotypic
control for the marker and detine the unspecific binding of the Ab used. For both pLN
and spleen the expression for each marker on pDCs and cDC is indicated in the
corresponding histogram as percentage and MFI values.
5. PDCS MATURATIONAL STATE AND RESPONSE TO IN VITRO STIMULATION: TG
MICE-DERIVED PLN AND SPLENIC PDCS SHOW A LOWER MATURATIONAL STATE
EX-VIVO. TG MICE-DERIVED PLN AND BM PDCS MATURATIONAL RESPONSE TO IN
VITRO STIMULATION IS ALTERED WHEN COMPARED TO NTG MICE.
Both cDC and pDC up-regulate their celI surface MHC class II expression upon maturation
[19]. In fact, MHCII—mediated Ag presentation by DC subtypes is dependent on a precisely
regulated ceIl type specific and quantitatively controlled pattern of MHC class II expression
[50]. In order to examine the state of maturation of Tg pDCs compared to nTg pDCs, FACS
analysis were done on ex-vivo DC-enriched celI suspensions from peripheral Iymphoid
organs. In addition, ceIl suspensions were prepared from BM and then enriched for DOs by
an advanced culture method that allows the elimination of granulocytes as described in the
CD4
L
CD4
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section on materials and methods and in the supplementary figure 14.A. BM-derived pDCs
MHCII expression was assessed ex-vivo and after DC-enrichment.
Results in Table-lll.A show that BM-derived pDCs express the same levels of MHCII
(percentage and MFI) in Tg and nTg mice. However, MHCII expression (MFI) on pDCs from
both spleen (Table lll.B) and pLNs (Table lll.C) is Iower in Tg mice compared to nTg. This
indicates a defect in the maturational state of Tg pDCs in the periphery but flot in BM, which
is a central lymphoid organ. In contrast to ex-vivo results, BM pDCs after 9 days of culture
for DC enrichment show lower expression of MHCII (% and MFI) when derived from Tg
compared to nTg mice.
Combinations of DC stimulants, which are known to induce maturation i.e., GM-CSF,
CD4OL and rIL-3 have been used for in vitro maturational assays [50]. Although, murine
pDCs unlike human pDCs do flot express high levels of IL-3R, they are expected to mature
moderately upon GM-CSF and rlL-3 stimulation [50, 35]. FACS analysis was per[ormed on
DC-enriched celI suspensions from BM, spleen and pLNs that have been cultured with
immunostimulants. Post-stimulation, MHCII expression is lower on pDCs derived from BM
and pLNs of Tg mice when compared to their nTg equivalents (Table-lll.A and -lll.C).
However, Tg mice-derived splenic pDCs express similar levels of MHCII than nTg splenic
pDCs after in vitro stimulation (Table-lIl.B). This later data suggests that Tg mice derived
spienic pDCs response to maturational stimuli must be higher compared to the response of
their nTg equivalents because stimulation rescued their ex-vivo phenotype of Iower MHCII
expression. For pLNs, the ratios of MHCII expression on pDC to cDC are reported in Table
lll.C. PDCs remain less mature than cDCs ex-vivo and post stimulation in Tg and nTg mice.
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EX VIVO MHCII % MHCII MFI
Tg/nTg 1.15±0.19 0.75±0.07*
POST-STIMULATION
TG/NTG 1.17±0.12 1.17±0.29
STIMULATION
TABLE-III. PDCS MATURATIONAL STATE AND RESPONSE TO IN VITRO
A.BM PDC
EX VIVO MHCII % MHCII MFI
TG/NTG 1 ±0 0.97±0.10
POST-ENRICHMENT
TG/NTG 0.70 ± 0.05 0.83 ± 0.07
POST-STIMULATION
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EX-VIVO MHCII% MHCII MFI
TG/NTG 0.85 ± QQ4* 0.77 ± 0.05*
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NTG 0.42 ± 0.23 0.36 ± 0.12
TG 0.41 ±0.13 0.35 ±0.23
POST-STIMULATION GM-CSF + CD4O] + rIL3
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Table III. PDCs maturational state and response to immunostimulants
A) BM-derived pDCs MHCII expression was assessed ex-vivo by FACS analysis on celI
suspensions obtained by BM flushing. Post-enrichment designate the use 0f the advanced
method of DC enrichment for BM as described in the section on materials and methods and
in supplementary figure 13.A [131]. Further stimulation was performed on DC-enriched celI
suspensions f rom BM by adding immuno-stimulants to the same media used for the
enrichment and allowing celis to stay in culture for another 24 hours. This later condition
corresponds to post-stimulation in Table III-A. MHCH expression is reported as the
percentage of gated pDCs expressing this molecule and as MFI, which corresponds to total
celI surtace expression of MHCII. Results are reported as ratios of Tg/nTg for each
parameter examined and SD (±) corresponds to variation between mice (n=4).
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B), C) DC enriched cell suspension was prepared from a pool of 3 Tg and 3 nTg mice as
described in the section on materials and methods. FACS analysis was done on DC
enriched cell suspensions ex-vivo f rom peripheral lymphoid organs. PDCs were identified
as described in figure 1.B. and MHCII expression on gated pDCs is reported in Table III.B
for spleen and III.C for pLNs. Post-stimulation corresponds to culture for 24 hours of DC
enriched celI suspension in the presence of a combination of immuno-stimulants including
GM-CSF, CD4OL and rlL-3, which are known to induce DC (including pDC) maturation [1,
50, 57]. Results are reported as ratios of Tg/nTg for each parameter examined. Two
experiments were done for spleen and pLNs maturational assay and SD (±) corresponds to
variation in the values of Tg/nTg ratios between experiments. The number of independent
experiments for pDCs MHCII expression ex-vivo was 4.
N.B. In pLNs, ex-vivo and post-stimulation, MHCII expression (¾ and MFI) was compared
between pDCs and cDCs and this is reported as ratios of PDC/CDC. In addition examples
of actual values of MHCII expression (¾ and MFI) are reported in the corresponding FACS
histograms following Table III-A, -B and C for BM, spleen and pLN pDCs, respectively.
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6. PDCS DERIVED FROM FLT3L-ENRICHED BM PRECURSOR CELLS AND THEIR
RESPONSE TO CPG: THE MATURATIONAL STATE 0F FLT3L-INDUCED PDCS
FROM BM IS SIGNIFICANTLY LOWER WHEN CELLS ARE DERIVED FROM TG
COMPARED TO NTG MICE. BM-DERIVED FLT3L-INDUCED PDCS MATURATIONAL
RESPONSE TO CPG IS SIMILAR WHEN CELLS ARE DERIVED FROM TG AND NTG
MICE.
FIt3L is a growth factor and the ligand for the receptor fms-like tyrosine kinase (Flt)-3, which
is a member of platelet-derived growth factor (PDGF)-receptor superamily [28], expressed
by a restricted subset of early multipotent hemopoietic progenitor ceNs [134]. This factor is
known to increase the number of DCs, B ceils and NK celis in aduit mice [135]. FIt3L
expands PDC population both in vivo and in vitro, and is also crucial for their development
in physiological conditions. In fact, Flt3L-deficient mice completely lack this specific DC
subset [43].
PDCs generation from BM precursor cells enriched with Flt3L was assessed comparing
CD4C,HIVm Tg to nTg mice. The purpose of this experiment was to verify if the
expression of Nef early in life at the embryonic stage, could affect BM residing pDC
precursor cells response to FIt3L. This question was addressed because in HIV-1 infection,
pDCs are depleted and among other mechanisms, their regeneration f rom BM precursor
ceNs might be inefficient. Moreover, FIt3L can be a useful tool to expand pDC population
since pDCs depletion correlates with immunosuppression and the augmentation of their
number during HAART is associated with immune reconstitution [107, 108, 709].
FACS panels in figure 6.A. show the expansion of BM pDCs in response to FIt3L by
comparing to ex-vivo BM-derived cells. As shown in figure 6.B., FIt3L-mediated pDC
expansion from BM precursor cells is slightly but not significantly decreased in Tg mice. The
maturational state of these pDCs, assessed by their celI surface expression of MHCII and
CD86 is significantly lower when they are derived from 1g compared to nTg mice (figure 6.C
and 6.D). Moreover, pDCs expression of Ly49Q was measured because of its association
with functional features of BM-derived pDCs [51]. A major proportion (about 80%) of FIt3L-
induced BM-derived pDCs from nTg mice express Ly49Q and this expression is slightly
decreased when pDCs are derived f rom Tg mice (figure 6.E).
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CpG stimulation is known to induce pDCs proliferation and maturation in vivo as well as in
vitro [47]. CpG is a specific ligand for TLR-9 and sinGe its effects on pDCs are mediated
through TLR-9 signaling pathway, pDCs response to CpG can provide information
regarding TLR-9 expression and/or signaling in pDCs [63, 71]. Further in vitro maturation of
Flt3L-enriched BM derived ceils was used to evaluate pDCs expansion and maturation in
response to CpG stimulation. Based on values ot CD11c MFI reported in FACS panels of
figure 6F, the expression of CD11c is up-regulated on CpG-stimulated pDCs-derived from
Tg mice and not from nTg mice. FACS results obtained after this maturational assay were
compiled and shown in figures 6G and 6H. In contrary to pDCs obtained post-FIt3L
enrichment of Tg mice BM cells showing a defect in their MHCII expression, maturational
response of pDCs induced by CpG is comparable between Tg and nTg mice.
FIGURE 6: IN VITRO FLT3L ENRICHED BM DERIVED PDCS AND CPG
STIMULATION
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FIGURE 6: In vitro FIt3L-enriched BM derived pDCs and their further
maturation by CpG
A) FACS analysis was done on total BM-derived ceils cultured in the presence of FIt3L, in
the form of supernatant from celis that have been transfected by a piasmid containing
mouse Flt3L gene (supplementary figure 13.B). The negative control for Flt3L
enrichment corresponds to BM-derived celis cultured with the supernatant from
transfected celis with an empty plasmid lacking Flt3L gene as described in material and
methods (supplementary figure 13.B). PDCs were defined as CD11cB220 celis. FIt3L
enrichment assays were done three times with BM cells from 2 mice in each experiment
(n=6).
B) Resuits obtained from FACS analysis on FIt3L enriched BM ceils were compiied. This
graph shows pDCs yieid detined as their percentage of live (PF) ceils. In each
experiment and for each mouse, the value obtained for pDC yield was fixed to 1 for nTg
and the ratios of Tg/nTg are reported with a y-error bar corresponding to SD between ail
resuits.
C) The maturationai state of FIt3L-enriched BM derived pDCs was assessed by their
expression of MHC11. in this graph the percentage of MHCI1 expressing pDCs as weii as
MFI of MHCI1 are reported as Tg/nTg ratios. The SD corresponds to variation in these
ratios between different mice and experiments (P 0.01).
D) This graph shows the expression of CD86 on FIt3L-enriched BM derived pDCs. Resuits
are shown similarly to graph C.
E) Ly49Q expression by Flt3L-induced pDCs is shown in this graph. However, this graph
shows preliminary resuits since data are obtained from only 2 mice in one experiment.
F) On day 9 of culture post-Flt3L enrichment, haif of the recovered ceNs were cuitured in
two different conditions: MA and CpG stimulation foliowing the same conditions as for
the enrichment (See section on further maturation in materiais and methods). FACS
plots showing pDC populations after culture in MA and CpG are shown here. FACS
histograms corresponding to MHCII expression on gated pDCs for both MA and CpG
conditions are shown. Examples of values obtained for MHCII expression (%, MF1) are
reported in these panels.
G) , H) The graph shows compiled FACS resuits of MHC11 expression on pDCs (¾ in graph
G and MFI in graph H), after furiher CpG stimulation. The resuits are reported as ratios
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of CpG/MA cf MHCII expression (%) in order to examine pDCs response to CpG
compared to MA used as a control.
7. TRANSPLANTATION CHIMERA MOUSE MODEL USED FOR THE STUDY 0F PDCS
A transplantation chimera mouse model has been designed in our Iaboratory in order to
study thymic T celi generation in CD4C/HIVmUtG mice (Pavel Chrobak et al., unpublished
data). As described in the section on materials and methods, chimeric mice were obtained
by injection of fetal liver cetis into irradiated syngeneic mice. The following diagram shows
the construction of these chimeras and the use of chimeric Tg mice for tracing Tg versus
nTg-derived cells based on the expression of different isoforms of the CD45 ceil surtace
marker.
i.Breeding for generation of embryos to use as donors (see section on materials and
methods)
2.Fetal liver preparation and injection into recipient mice
MixA
_____________
Donor:
nTg CD45.i C3H : 66% + Tg CD45.2 C3H: 33%
lnjected into
Recipient:
nTg CD45.2 C3H, 900 Rads irradiated
chimeric nlg mice
MixB
nlg CD45.1 C3H 66% CD4CJfflV Tg CD45.2 C3H: 33%
lnjected into
nTg CD45.24C3H, 900 Rads irradiated fRecipient:
______________________________ _ _ _ _ _
chimeric Tg mice
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The above diagram shows that the same proportion of CD45.1 (66%) and CD45.2 (33%)
ceils were injected into the recipient mice to produce both chimeric Tg and chimeric nTg
mice. Figure 7.A shows the percentage of chimerism, which corresponds to the relative
proportion of CD45.1 and CD45.1 cells, in difterent spienic immune ceil populations.
Values of the percentage of chimerism must be compared between chimeric Tg and
chimeric nTg mice in order to evaluate potential differences in the reconstitution of
peripheral immune celis between CD45.1 and CD45.1 celis.
As shown in figure 7.A, for NK ceNs, macrophages and B ceils, the proportion of CD45.1
relative to CD45.1 ceils is similar or slightly different in chimeric Tg compared to chimeric
nTg mice. In contrast, for CD4 and CD8 T ceils, the ratio of CD45.1 to CD45.1 celis is
significantly higher in chimeric Tg compared to chimeric nTg mice. Same experiments in
pLN show similar resuits for CD4 and CD8 T ceils as in spleen suggesting a defect in T
ceil generation from Tg mice-derived ceNs (Pavel Chrobak, unpublished data).
Chimera mouse model was used to determine the in vivo effect of Nef expression by
transgene expressing celis derived f rom CD4C/HIVmUtG Tg CD45.2 donor on nTg ceils f rom
nTg CD45.14 donor since they are both present in chimeric Tg mice. This effect
corresponds to the indirect effect of Nef as opposed to the direct effect of Nef, which refers
to its effect on celis expressing the transgene. The indirect eftect of Net can be evaluated by
comparing, between chimeric Tg and chimeric nTg mice, the characteristics of celis derived
from nTg progenitors, which are CD45i ceNs. In fact, CD45.1 celis in both nTg and Tg
chimeras are derived f rom nTg mice progenitors, but in chimeric Tg mice, in contrast to
chimeric nTg mice, this population is in the presence of Tg-derived cells (CD45.1). It should
be noted that CD45.f ceils in chimera mouse model may include a minority of residual host
celis from the recipient mouse, which have flot been eradicated by irradiation [133]. Thus
CD45.1 celis are not comparable in chimera mouse model.
We have used this model to study the indirect effect of Nef on various features of pDCs
generated from FIt3L-enriched BM cells. As shown in figure 7.B.1, the relative frequency of
CD45.1 and CD45.ï cells among live pDCs is equal between chimeric Tg and chimeric
nTg mice. This suggests that in Tg mice, pDC precursors among BM ceils display no defect
in their potency to generate pDCs in response to FIt3L.
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The examination of the maturational state 0f FIt3L-enriched BM derived pDCs revealed that
CD45.1 cells in chimeric Tg mice show slightly higher level of MHCII e xpression
(MFI)compared to their equivalent ceH population in chimeric nTg mice (figure 7.C). This
difference may be due to an indirect effect of Tg mice-derived ceils on nTg mice-derived
ceils in chimeric Tg mice. The slight increase in MHCII expression of nTg pDCs (CD45.1 in
chimeric Tg mice) could reflect a compensatory mechanism in the presence of Tg ceils,
which show a maturational defect (figure 60 and 6D). In fact, maturational factors such as
IFN-a may be produced in excess in cultures from chimeric Tg mice in order to compensate
the maturational defect of Tg mice derived pDCs.
FIGURE 7: CHIMERIC MOUSE MODEL
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FIGURE 7: Transplantation chimera mouse model
Total of 5 chimeric Tg and 4 chimeric nTg mice have been prepared by fetal liver
transplantation (Material and methods). FACS analysis was done on celI suspensions
prepared f rom spleen and FIt3L-enriched BM cells. Figure 7.A and 7.B show the compilation
of FACS resuits obtained f rom four experiments for the spleen and three experiments for
FIt3L-enriched BM cells, respectively.
In each experiment, one C3H Tg mouse was used as a positive controf for the expression of
CD45.2 and one CD45.1 congeneic mouse (C3H), was used as a positive control for the
I
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expression of CD45.1 (supplementary figure 15). In ail experiments, celis were stained for
markers of immune ceil populations and either CD45.1 or CD45.2 in independent wells.
CD45.2 staining was used as a control for staining ail ceils (CD45.1 and CD45.ï ceils)
originating from both parents in chimeric mice.
A) The percentage of chimerism was obtained by FACS analysis on total spienocytes after
RBCs were removed. Each immune celi population was identified according to their
specific markers. B celis were defined as B220IgW cells, CD4 T cells as
TCRaICD4, CD8 T ceils as TCRaII3CD8 cells, macrophages as CD11bCD11c
cells and NK cells as CD3DX5 cells. The proportions of CD45.1 to CD45.1 cells were
determined in each population.
B) 5M cells were enriched with FIt3L as described in the section on materials and methods
and in the legend of figure 6.A. Figure 7.B.1. shows data obtained from FACS analysis
on recovered cultured ceils from both chimeric Tg and chimeric nlg mice reported as the
percentage of CD45.1 and CD45.lceiIs among live (PF) pDCs that have been yielded
in vitro post-FIt3L enrichment of 5M cells. In figure 7.B.2 pDCs maturational state is
reported as MHCII expression (percentage and MFI). MHCII expression on CD45.1
pDCs is compared between chimeric Tg and chimeric nTg mice in order to evaluate the
indirect effect of Nef.
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8. PDCS LOCALIZATION: PDC SHOW AN UNUSUAL HOMING IN VARIOUS ZONES
0F PERIPHERAL LYMPHOID ORGANS IN CD4C/HIV TRANSGENIC MICE.
Previously, histological examination revealed abnormalities in the spleens of CD4C/HIV Tg
mice including partial to extensive loss of spienic architecture, frequent hypoceilularity, and
occasionally fibrosis. Such extensive destruction of the Iymphoid organs is iikely to severely
affect the function of the immune system [74]. In addition, an unusual mDC homing has
been reported in peripheral lymphoid organs of Tg mice [119], and since pDCs trafficking is
known to be implicated in mDCs migration to LNs [45], pDCs Iocalization in LN and spleen
of Tg mice have been examined.
As shown in figures 8.A.2 and graph 8.C., contrary to nTg mice, pDCs are absent or very
few in the spienic T zone of Tg mice. Figure 8.B and graph 8.D show a lowered number of
pDC in B-T celi transitional zone of Tg compared to nTg mice. PDCs are few but similar in
both Tg and nTg marginal zone (MZ) (graph 8.E.) In pLNs, pDCs number in T zone is
similar in Tg and nTg mice, but their number is lower in B-T transitional zone and enhanced
in SC zone of Tg mice compared to nTg animais fgraphs 8.F, 8.G and 8.H). Thus, pDCs in
the lymphoid organs of Tg mice display a homing defect. These unusual iocalizations couid
refiect a migrationai defect of pDCs in Tg mice.
FIGURE 8: PDCS LOCALIZATION
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8.B. Spleen T and T-B celi transitional zone
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FIGURE 8: PDCs Iocalization
IHC was done on spleen and LN of CD4C/HIVmut’ Tg mice and nTg littermates. Resuits
are shown in figure 8.A. for spleen and 8.B. for pLN. IHC technique was used on frozen
tissue sections (see materials and methods). Pictures were taken by either contocal or
Axiovert microscopy at 40X level of magnification. The number of experiments was 3. In
each experiment 3 Tg and 3 nTg littermate mice were used. Average number of tieids
counted per spleen was 10. One peri-arteriolar lymphoid sheath (PALS) was visualized
per tield as shown in figure 8.A.1. In the picture of figure 8.A.1, T-cell and B-cell zones
are visualized at 20X magnification and B celis are seen in red by IgM-Texas Red
staining. In figures 8.A.2, 8.B. and 8.H, pDCs are visualized as yellow by the
superimposition of CD1 ic Alexa-red and B220 FITC-green staining.
Resuits obtained for pDCs number visualized by IHC in different regions of peripheral
Iymphoid organs are compiled and reported in graphs 8.0, D and 8.E for spleen and 8.F,
8.G and 8.H for pLN. SDs (Y-axis error bar) refers to intra and inter-experiments
variations in pDCs number counted on ail siides.
9. PDC INTRACELLULAR CONTENT IN IFN-ALPHA: SPLENIC PDCS DERIVED
FROM THE CD4C/HIV TG MICE CONTAIN HIGHER LEVEL 0F INTRACELLULAR
IFN-ALPHA AS COMPARED TO THEIR EQUIVALENTS FROM NTG MICE.
In order to measure pDCs content in IFN-a, the technique of intracellular staining by IHC on
permeabilized pDCs was used as described in the section on materials and methods. The
major subtype of IFN-a produced by pDCs is IFN-A1 [86]. The Ab used in this experiment
specifically detects 5 isoforms of IFN-a including Al. Preliminary results obtained from this
experiment revealed a significant augmentation of IFN-a in Tg compared to nTg mice
derived PDCs. As shown in figure 9, ceils containing high level of IFN-a are more abundant
in the Tg mice derived spienic pDC population.
This resuit may reflect a higher production of the cytokine by pDCs. More experiments using
ELISA along with intracellular FACS techniques are necessary to document pDCs IFN-a
production ex-vivo and under different in vivo and in vitro conditions.
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FIGURE 9: PDCS INTRACELLULAR CONTENT IN IFN-ALPHA
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FIGURE 9: PDCs intracellular IFN-a
Spienic pDCs were sorted from a pool of 6 Tg and 6 nTg mice. Purified IFN-a specific
antibody (Ab.) was used in 1HC reactions on cytospins of freshiy sorted and
permeabiiized pDCs as described in materials and methods (See section on
immunofluorescence). The level of Ab. staining was measured by Northern Eclipse
software as green fluorescence iuminosity. About 20 fields of each Tg and non-Tg
derived pDCs were examined (figure 9.B). The quantification of IFN-a staining was
reported in the graph 9.A comparing ail populations of pDCs and CDCs from Tg and non
Tg mice. FITC alone representing the staining of cells with the secondary antibody alone
as well as isotypic controls for the primary Ab against IFN-o have been used to subtract
nonspecific binding (figure 9.B.). The non-specific background staining corresponds to
green fluorescence luminosity <75 and is subtracted prior to data compilation (graph 9.A,
x axis). The experiment has been done one time.
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1O.THE EFFECT 0F IN WVO CPG ADMINISTRATION ON IMMUNE CELL
POPULATIONS: PRELIMINARY RESULTS SHOW THAT PDC MOBILIZATION INTO
BLOOD AND MATURATIONAL RESPONSE TO CPG ARE NOT ALTERED IN TG
MICE. IFN-ALPHA-MEDIATED EFFECTS 0F CPG CAUSING NK CELL ACTIVATION
AND MDC MATURATION ARE PRESERVED IN TG MICE.
Bacterial DNA contains a high frequency of CpG motifs, which stimulate immune celis
through TLR-9 [63]. Synthetic CpG mimic bacterial DNA and its injection into mice and
humans has been shown to cause pDC mobilization into blood, maturation and production of
IFN-a [35, 71]. This cytokine induces mDC maturation and augments mDCs Ag-presenting
function [73]. In addition, CpG induce NK ceil activation, including enhanced cytotoxicity and
celi suriace CD69 up-regulation [136, 137]. Both, pDC and mDC are required for NK celI
activation in response to CpG and IFN-a is a strong inducer of CD69 expression on NK cells
[23, 137]. Moreover, TLR-9 signaling pathway blocks the suppressive effect of CD4CD25
Tr cells allowing T ceil stimulation by activated APCs [72]. It has been reported that pDC are
defective in the induction of monocyte maturation in response to CpG in HIV patients [47).
In mouse, contrary to human, B cells and pDCs are not the only immune celi populations
expressing TLR-9, which is also expressed by mDCs [68]. In order to evaluate the effect of
Nef expression on pDC and mDC response to TLR-9 stimulation in vivo, we administered
CpG to above mentioned CD4C/HlVmutG Tg mice.
Preliminary results show that pDCs response to CpG in terms of their mobilization into the
blood and maturation in pLNs s equivalent between Tg and nTg mice (figure 10.A). Figure
10.B shows that NK cell frequency in Tg mice pLN s increased compared to nTg mice,
decreases upon in-vivo CpG stimulation in a dose-dependent manner. However, this finding
may also be due to downregulation of Dx5 on Tg NK ceil population post-CpG stimulation.
In addition, NK cells expression of CD69 augments equally in Tg and nTg mice in response
to CpG stimulation (figure 10.B). Similarly, as shown in figure 10.C, mDC maturation in
response to CpG s conserved in Tg mice. As shown in figure 10.D, peripheral CD4h1 T celis
are increased and CD4 is up-regulated on CD4 T cells of Tg mice in response to CpG
injected at 200 pg and not at 100 pg. Intrestingly, this partial rescue eftect on CD4 T cells
downregulation and depletion is observed at the same condition (CpG injected at 200 pg),
which caused a decrease in abnormally elevated frequency of CD4CD25 T cells in Tg
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mice. Although, these CD4CD25 ceils are known to correspond to regulatory T ceils in
normal mice, they have not been characterized as regulatory ceils in Tg mice. In contrast to
Tg mice in which the immune system is dysfunctional, in nTg mice CD4 T cells are slightly
decreased may be because of the slight increase in CD4CD25 Tr cefls population as
expected in physiological conditions [60].
FIGURE 10. The effect of Iii-VIVO CpG stimulation on immune ceils
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FIGURE 10. The effect of in-vivo CpG stimulation on immune cells
A class-C CpG-ODN was injected at a dose of either 100 pg into 2 nTg and 2 Tg mice as
described in materials and methods. One nTg and one Tg mice have been injected with
PBS as a negative control. Immune-celi population frequency, activation and maturational
markers were measured by FACS 24 hours post-injection cf CpG. Similar resuits were
obtained in spleen and pLNs.
A) FACS resuits are reported on gated peripheral pDC population identified as
CD1 1 cb0B220+LY49Q+ cells. The two first graphs show pDC frequency (% and absolute
cell number) in blood. The third graph shows pLN pDC state of maturation reported as
MHCII expression (% and MFI).
B) This graph shows NK cell population frequency as percentage cf total pLN live cells. The
FACS histograms show CD69 expression on gated NK ceils in nTg and Tg mice. The
percentage and MFI of CD69 are reported for each mouse including, PBS and CpG
inlected mice. Results obtained trom spleen and pLNs are reported for NK celI CD69
expression.
C) FACS histograms show the expression of the costimulatory molecule (CD86) on gated
pLN mDCs defined as CD1 1 bCD1 1 cB220 cells.
$6
D) D.1 and D.2 show FACS analysis on CD4 T ceils in pLNs and spleen, respectively.
FACS histograms show CD4 expression on pLN TCRa/13 cells. The graph shows pLNs
CD4h1 T celI frequency in Tg and nTg mice. in nTg mice, ail CD4 T cells express high
level of CD4, while in Tg mice CD4 is down-regulated [138].
E) This graph shows the frequency of CD4+CD25hi T ceils among pLN TCRa/CD4 T
celis.
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CHAPTER 4: DISCUSSION and FUTURE WORK
In this study, pDCs were examined in the context of the CD4C,HIVmutG Tg mice in which Nef
expression in natural target celis for HIV causes a multiorgan inflammatory disease and
immune dystunctions sharing common features with AIDS. PDCs characterization s part of
investigations on the immune system dysfunctions in CD4C/HIV Tg mice [104, 115, 117].
Recently, multiple defects in cDC population have been reported in this mouse model [1 19].
The study of pDCs in CD4C/HIV Tg mice revealed the following characteristics when
compared to nTg mice.
In Tg mice, 40 to 60% of spienic and 25% of pLNs pDCs express Nef. PDCs in Tg mice
pLNs express higher level of the cell surface marker CD1 1 c and show altered size and
granularity as indicated by their light scatter characteristics in FACS analysis. However, Tg
mice-derived splenic pDCs show a normal morphology based on Giemsa staining as well as
FACS light scatter parameters. Since pDCs residing in these two lymphoid organs may
differ in their characteristics, the morphology of pLN pDCs should also be examined by a
direct technique as Giemsa staining in order to investigate their altered FACS light scatter
features. The frequency of pDCs s increased in blood and pDCs distribution as well as their
homing is unusual in the peripheral lymphoid organs of Tg mice. Peripheral pDCs derived
from Tg mice display an immature phenotype compared to their nTg equivalents. In
addition, in the peripheral Iymphoid organs of Tg mice, pDCs surface expression of CD4
and CD8 is reduced and CD4 as well as CD8 pDCs are depleted. Moreover, based on
preliminary results, the level of intracellular IFN-o is higher in pDCs f rom Tg mice than f rom
nTg mice.
In vitro assays show that splenic pDCs trom Tg mice contrary to nTg mice survive less in
stimulated culture conditions compared to MA. In vitro, the maturational response of pLNs
pDCs to stimulants is lower when they are derived from pLNs of Tg as compared to nTg
mice. In contrast to peripheral pDCs, Tg mice derived BM pDCs show a normal
maturational profile ex-vivo. However, in vitro, Tg BM pDCs maturational response to
stimulation with a combination ot GM-CSF, CD4OL and rIL3 is reduced. In addition, pDCs
yield f rom Tg BM post-Flt3L enrichment is slightly but not significantly decreased and their
maturational state is significantly lower compared to nTg mice-derived pDCs. However, the
maturational response of FIt3L-induced pDCs to CpG is comparable between Tg and nTg
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mice. Resuits obtained frem pDCs study in transplantation chimera mouse medel suggest
that in Tg mice pDCs precursors among BM cells display no defect in their potency to
generate pDCs in response to FIt3L enrichment.
Preliminary results obtained f rom in vivo CpG-stimulation show an equivalent response in
Tg and nTg mice concerning pDC and mDC maturation and NK cells activation. Since
TNFa and IFNa are required for NK cell CD69 up-regulation [23], the secretion of these
cytokines by DC subsets in response te CpG might be conserved in Tg mice. In addition, in
contrary to humans, in mouse flot only pDC but also other DC subsets express TLR-9 and
can be directly activated by CpG [68]. This could explain why mDCs maturational response
is not altered in Tg mice in contrast to the impairment of monocyte maturation in response
to CpG observed in humans [47].
Intrestingly, CpG injected at the dose cf 200 pg decreased the abnormally elevated
frequency of CD4+CD25hi celis in Tg mice. At this dose cf CpG stimulation, a partial rescue
effect was observed in CD4 dcwnregulatien en CD4 T celI and their depletion. This effect
observed in spleen as well in pLNs of Tg mice may be hypothetically due te the
augmentation cf total CTLs, since NK celis as well as CD8 T cells are activated upon in
vivo CpG stimulation [46, 136]. These activated cells may lyse CD4’° T cells, which
correspond to celis expressing high levels cf Nef [138]. This latter effect increases the ratio
cf survival factors in Tg lympheid organs, allewing the regeneratien cf CD4hi T cells kncwn
te express low levels cf Nef [138]. Morecver, since only at the dose cf 200 pg CpG induces
a decrease in abnermally elevated levels cf CD4CD25 T ceils, the blcck in the
suppressive effect cf Tr ceNs may allow CTLs te kilI viral gene expressing CD4I0 T cells and
activated DCs te stimulate and expand CD4 T cells [21, 40]. In tact, DCs maturaticn upen
TLR stimulation causes cytekine production such as IL-6, which renders naïve T ceils
refractory te the suppressive effect et regulatcry T cells and induces their proliferatien [72].
AIse, the depletion cf Tr cells may enhance T celI regenerative pathways. However, the
mechanisms cf TLR-mediated contrel cf adaptive immunity are not yet completely
described [72]. In order te test the abeve hypothesis, the in-vivo CpG stimulation sheuld be
repeated. Mcrecver, CD4+CD25h1 regulatcry T cells must be identified by the use cf an Ab
against FoxP3, which is a transcriptional facter specifically expressed by these cells [72].
AIl these defects cbserved in Tg pDCs cculd be due either te a direct effect and/cr te an
indirect eftect cf Nef expression since enly ene part cf pDCs express Nef. PDCs Iower
maturaticnal state in the periphery cerrelates with ether DCs immature phenetype in
CD4C/HIV Tg mice [119]. In erder te further investigate the defects in Tg pDCs MHCII
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expression, the level of expression of CIITA, which is a transcriptional coactivator acting as
the master regulatory factor for ail MHC class ii genes could be evaluated [19]. in contrast
to peripheral pDCs, BM pDCs from Tg mice do flot show a defect in their maturational state.
However, since in BM pDCs are precursors that give tise to blood pDCs and are immature
compared to peripheral pDCs, a defect in their maturational profile may be undetectable at
this stage. Peripheral pDCs immature phenotype as weii as the depietion of CD4and CD8
pDCs suggests that pDCs at a less difterentiated stage, corresponding to CD4CDS subset,
are accumulating in Tg mice [50]. The accumulation of immature pDCs in Tg mice is also
indicated by data showing an increase in blood pDCs, which are mostly composed of CD4
CD8 subset and are precursors of pDCs in peripheral lymphoid organs [50].
On the other hand, the phenotypic alterations of pDCs derived f rom Tg mice can teflect a
defect in their function, which correlates with pDCs stage of maturation. in fact, pDCs are
known to produce 1FN-a at a less differentiated stage and act as APCs upon maturation [42,
501. Thus preliminary data showing an increase in Tg mice pDCs intracellular IFN-a is in
accord with their immature phenotype, if we assume that the level of intracellular 1FN-ci
reflects its production by pDCs. However, since 1FN-a is produced rapidly after viral
infection [139], the finding of elevated ievei of this cytokine must be interpreted considering
the particular context of Tg mice. in fact, in this mouse model contrary to HIV infection in
humans, there is no virai infection and no reinfection cycle occurs in Tg mice. The level of
transgene expression in Tg mice is likely to mimic a steady state viral load of virus
expression in humans [1 16]. In addition, to precisely evaluate the production 0f IFN-a by Tg
pDCs, EL1SA technique must be used to detect this cytokine in the serum of Tg and nTg
mice and in culture supernatant under different pDC stimulation conditions. On the other
hand, pDCs Ag-presenting function, which also depends on their maturational state [42],
should be evaluated in Tg mice. This function can be assessed by an allogeneic mixte
leucocyte reaction (MLR) experiment in which sorted pDCs from pLNs, spleen or Flt3L-
enriched BM cells are stimulated O.N. with anti-CD4O Ab. Serial dilutions of in vitro—
stimulated pDCs are cocultured with allogeneic CD4 T cells and T cell proliferation is
measured by thymidine incorporation assay [35].
The defects in pDCs phenotype and function can contribute to or caused by dysfunctions of
the immune system described in Tg mice. For example, immature pDCs have been shown
to induce the difterentiation of Tr cells [31,58] suppressing Ag-specific T cell proliferation as
observed in Tg mice [119]. In addition, since CD4OL is required for pDCs maturation in vivo
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[50], Tg mice-derived pDCs phenotype may be caused by the decrease in CD4OL, as
reported in Tg mice [118].
The immature phenotype of peripheral pDCs derived from Tg mice may also contribute to
their defective homing in peripheral Iymphoid organs. In fact, pDCs migration to T zones of
pLNs and spienic white pulp depends on the level of expression cf CCR7 on pDCs surface,
which is upregulated following their maturation [11, 15]. In addition, only after maturation by
stimulants such as CD4OL that CCRs on pDCs surface beccme functional and induce their
migration te peripheral lymphoid organs [13]. Therefore, Tg mice-derived pDCs immature
phenotype may indicate a defect in pDCs migratienal response te CCs causing their
unusual homing. In Tg mice, pDCs are reduced in T zones of pLNs while they are absent in
T zones of spleen. This difference between spleen and pLNs in pDCs homing may be due
te the direct access cf blocd pDCs te pLNs through HEVs, which are net present in the
spleen [13, 64, 67]. This supplementary route of migration to pLNs apart f rom afferent
Iymphatics, may explain why a defect in the level et CCR7 expression on pDCs surface do
net prevent completely their migration te T zones cf pLNs as is the case for spleen.
Moreover, specific and different sets of chemekines are required fer pDCs trans-HEV
homing te pLN directly from blcod compared te their splenic homing threugh afferent
lymphatic vessels. Thus, apart from pDCs maturational defect, alteration in chemckines
such as CCL19 in the inflammatory context cf Tg mice may participate partly in their
abnermal trafficking te peripheral Iymphoid ergans by favering their homing te inflamed
tissues [11, 13, 56]. Measuring pDCs expression level of CCR7, CXCR3 and CD62L, which
is necessary fer trans-HEV pLN heming en pDCs surface aleng with the quantification et
CCs such as CCL19, CCL21 and CXCL9 in peripheral lympheid ergans, may be helpful for
better understanding cf the unusual pDCs localizatien in Tg mice [48, 64]. PDCs lewer
frequency in T zones cf pLNs and their absence in T zones cf spleen may ccntribute te the
anergic state observed in Tg mice. In fact, the release of cytokine by pDCs in the
microenvironment cf T zones is important fer shaping a T celI respense by linking the innate
and adaptive immunity [42].
This study shows an abncrmal viability cf Tg pDCs in vitro. Tg pDCs are more viable than
nTg pDCs in MA and less than nTg pDCs in stimulated conditions. The higher viability cf Tg
mice-derived splenic pDCs in MA is in accerdance with the finding that in vitro HIV infected
pDCs survive more than non-infected pDCs, mcst prebably due te the production cf IFN-o,
which is a knewn survival factor [113]. Acccrdingly, an increase in Tg mice-derived splenic
pDCs content cf IFN-a was ebserved as mentioned previously. In the other hand, the lewer
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viability of Tg mice-derived pDCs in stimulated culture conditions may be due to their higher
death following their maturation. In fact, it has been shown that HIV-1 infected pDCs form
multinuclear syncytia cells and die upon maturation and both DC subsets depletion in HIV-1
infected patients’ blood is partly due to their maturation [45, 140]. Further investigation for
pDCs survival in vivo could include the measurement of the level of cytokines required for
pDCs survival such as TNF-a and IFN-a as well as the expression of TRANCE-R on pDCs
[64, 113]. The defect in Tg pDCs survival in vitro may reflect pDCs abnormal turnover in
vivo, which can be examined directly by kinetic assays using 5-bromodeoxyuridine (BrdU)
labeling [1].
It should be noted that pDCs are augmented in blood of Tg mice in contrary to their
reduction in HIV-1 infected subjects. However, only one of HIV genes is expressed in Tg
mice and pDCs disappearance from patients’ blood could be a consequence of other HIV
proteins functions. The observed augmentation in pDCs frequency in blood mimics a long
term non-progressor status in humans [107, 108]. This can be due to the similarities
between AIDS-like disease in Nef Tg mice and a chronic suboptimal infectious condition
inducing an anergic immune state.
CD11c is expressed at higher levels in Tg than nTg mice derived pDCs based on values of
CD11c MFI in pDC population from pLN and from Flt3L-enriched BM precursor ceils
stimulated with CpG. Thus, the same shift in CD1 1 c expression is observed in pLN-derived
than in CpG stimulated BM-derived pDCs. In addition, since CpG stimulation of pDCs
specitically activates the TLR-9 signaling pathway [71] and induces CD1 lc upregulation in
pDCs from nTg and Tg mice (figure 6.F), the similarity observed in the phenotype of Tg pLN
and CpG stimulated pDCs, suggest that TLR-9 signaling pathway may be activated on pLN
pDCs due to Nef expression in Tg mice. If this hypothesis is exact, Nef-expressing pDCs in
pLNs of Tg mice are chronically activated. This suggests that Nef-mediated chronic
activation of TLR-9 signaling pathway in pDCs may contribute to the impaired induction of
the maturational response of monocytes to CpG observed in HIV-1 infected patients [47].
It is known that pDCs are the homeostatic counterpart of mDCs and they are believed to
modulate DC, NK and macrophages functions [50]. Since pDCs play multiple regulatory
roles in the innate immune system and because of their impairments observed in Tg mice,
the innate immune system may be dysfunctional in these mice. Accordingly, as
inflammation is an indicator of the activation of innate immune responses, defects in pDCs
characteristics including higher IFN-a production may contribute to the chronic inflammatory
organ disease observed in CD4C/HIV Tg mice [116].
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In conclusion, since pDCs show many abnormal features in CD4C/HIV Tg mice, they may
be implicated in immune dystunctions cf the AIDS-Iike disease. Since pDCs count
correlates with CD4 T ceil count in HIV-1 infected patients, we can examine the effect of
pDCs depletion, expansion and/or maturation on the immune system, particularly on CD4T
ceil frequency, in Tg mice. PDC population can be depleted, expanded and or stimulated by
injection into Tg and nTg mice of a depleting Ab such as mPDCA-1 [48], FIt3L and CpG
respectively, into Tg and nTg mice. Data obtained on FIt3L-induced pDCs suggest that
pDCs precursors in BM of Tg mice expand in response to FIt3L, at the same levels than
their equivaients in nTg mice. In addition, based on preliminary resuits obtained from in-vivo
CpG stimulation, pDCs and IFN-u-mediated response to CpG is equivalent in Tg and nTg
mice.
Moreover, the injection of 200pg of CpG induced CD4 upregulation on CD4 T ceils and a
siight CD4 T ceil repletion. The partial rescue effect of CpG on CD4 down-regulation of
CD4 T ceils and their depletion in CD4C,HIVmUIG Tg could be promoted by prior pDC
expansion with Flt3L followed by CpG injection at 200pg [141]. In addition, since
CD4CD25 regulatory T celis as weli as IL-10 are known to inhibit pDC response to CpG,
the concomitant injection cf an anti-IL-1 0-neutralizing Ab may optimize the cytokine milieu
to aiiow CD4 T ceil proliferation [16, 136, 142]. In these experiments, pDCs frequency,
phenotype, Iocalization, IFN-a production and Ag-presenting function shouId be assessed.
Moreover, other immune ceil populations, which are known te be directly or indirectiy
regulated by pDCs, could be examined. These ceil populations include NK ceIls [43, 63], B
cells [37, 58], mDCs [47, 85], CD4 heiper T cells [47, 80] and CD4CD25 Tr ceIls [60].
This experiment may allow a reversai cf CD4 T ceil depietion observed in Tg mice and may
heIp te elucidate the eftect cf pDC maturation on the immune system homeostasis in
CD4C/HIV Tg mice.
CHAPTER 5: CONCLUSION
In Tg mice compared to nTg littermates we observed:
• PLN pDCs show a shift into higher ceil surface expression 0f CD11c and different light
scatter characteristics.
• In Tg mouse 40 to 60% of splenic and 20 to 25% of pLN pDCs express Nef.
• In the BM of Tg mice, pDCs maturational state ex-vivo is normal while their state of
maturation post-FIt3L enrichment is significantly decreased.
• Contrary to BM, peripheral (spleen and pLN) pDCs maturational state is Iower ex-vivo.
PLNs pDCs stimulation with a combination of immunostimulants does not rescue their lower
ex-vivo maturational state.
• PDCs frequency is augmented in spleen and blood, decreased in pLN and unchanged in
BM.
• In addition, in the peripheral iymphoid organs of Tg mice, pDCs surface expression of CD4
and CD8 is reduced and CD4 as well as CD8 pDCs are depleted.
• In vitro culture assays of splenic DCs show that tg-mice pDCs have an increased survival in
medium alone and a reduced viability in stimulated conditions.
• PDCs in the lymphoid organs of Tg mice show a homing defect. PDCs are absent in the
splenic T celI zone and lowered in the transitional B-T cell zone ot Tg versus nTg mice.
They are few in nTg MZ and are equally present in Tg and nTg MZ. In Tg pLN, pDCs
number is similar to nTg in T ceIl zone, Iower in B-T transitional and enhanced in sub
capsular zone compared to nTg pLN.
• Preliminary results show that Tg mice-derived pDCs contain more IFN-cx than nTg pDCs.
• Preliminary results obtained from in-vivo CpG stimulation show that pDCs and mDCs
maturational response is conserved in Tg mice.
This research is useful in the context of investigating the effects of each of HIV-1 viral
products on cellular tunctions and their contribution to the development of AIDS. lt should
be mentioned that part of these results has been obtained in-vitro and their physiological
relevance remains to be determined by in-vivo experiments.
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CHAPTER 7: Supplementary Figures
I. Antiviral effects
Figure 11: IFN-alpha tunctions [84]
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Figure 12: Interferon-producing plasmacytoid dendritic celis and the
pathogenesis of AIDS [139]
A. A model of how interferon-producing ceNs (pDCs) may play a role in the
interface of innate and adaptive immunity
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B. A model of the hypothetical role of pDCs in the Ioss of Th-1 immunity in
HIV infection and how these events Ieads to HIV pathogenesis
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Figure 13: CD4C/HIVmutG transgene
CD4C/HIVmUtG transgene was constructed by fusing 14.4 kbp CD4C promoter (Hanna et
al., 1994) to 8.8 kbp BssHIl-Sacl fragment of HIV-1 NL4-3,i, in which ail genes except
for nef gene were mutated, and the simian virus 40 polyadenylation sequences. The
CD4C promoter consists of 12.5 kbp upstream sequences of human CD4 gene
containing 2.6 kbp of 5’ upstream sequences, exon 1, intron 1 and few bases at the
beginning of exon 2, as well as the 1.9 kbp mouse CD4 enhancer at the 5’ end [176].
cD4c,Hlvm transgene is essentially similar to CD4C,HIVmUtG with the exception that
besides H IV-1 Nef gene it also retains the Rev and Env genes of H IV-1 [17 6].
it Lt IIIh’
1 tJ.q-.I•
;F1
Sturcture of CD4C/HIVmuts: The transgene consists of mouse CD4 enhancer (mCD4
enh.) human CD4 promoter (hCD4C prom.), HIV-1 NL4-3 mutant genomes and SV4O
polyadenylation sequences. The symbol (X) indicates the interruption of the
corresponding HIV genes. Restriction sites: A, Aatll; Bs, BssHlI; S, SstI. Figure was
modified with the permission of the authors [1161.
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Figure 14: BM-derived DCs and pDCs
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Supernatant containing FIt3L was obtained by transient transfection (TT) of 293 T
cells. The graph shows the titration of this supernatant compared 10 commercialFIt3L. For titration of FIt3L, Baf3 cells were used which are known to proliferate in
response to FIt3L. Since the percentage of the supernatant used in the culture mediafor pDC induction from BM progenitor celis was 20%, the quantity of FIt3L in the
culture corresponds to 35 ng (as indicated by the arrow).
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Figure 15: BM post FIt3L enrichment in
chimeric mice model
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